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ABSTRACT 
The DEFB103 gene is a member of the β-defensin gene family, and it has not been well 
studied in cattle. In this study DEFB103 gene expression, gene structure and its haplotypes 
association with three diseases were studied. DEFB103 gene expression was profiled for 27 
tissues in nine two-week old calves and the transcript was most abundant in tissues with 
stratified squamous epithelium. An age-dependent decrease (P <0.05) in DEFB103 gene 
expression was observed in buccal epithelium when comparing healthy two-week old and 10- to 
12-month-old calves. A bovine herpesvirus-1 respiratory infection did, however, significantly (P 
< 0.05) up-regulate DEFB103 gene expression in the buccal epithelium of 6- to 8-month-old 
calves. Immunohistochemistry was used to identify cells expressing DEFB103 protein within 
tissues with stratified squamous epitheliums to confirm the DEFB103 gene expression results. 
DEFB103 protein was most abundant in basal epithelial cells and was present in these cells 
before birth. A close association was observed between the dendritic cells and epithelial cells 
expressing DEFB103 in both the fetus and newborn calf, and this is consistent with the β-
defensin regulatory effect on dendritic cell responses.  
DEFB103 cDNA boundaries were determined using RT-PCR. A newly discovered non-
coding exon 1a and a 261 bp intron 1a were identified in cattle. At least two complete copies of 
DEFB103 with an ATG start codon are present in cDNA in some cattle. DEFB103 sequence 
assemblies and partial cloning cloning sequences revealed two types of deletion (4-bp and 8-bp) 
in the 5′UTR.  
Two novel SNPs were identified in the 5′UTR of the DEFB103 (c.-383A>G, c.-241G>A) 
in addition to five (c.-319A>G, c.-264C>T, c.-69A>G, c.-42A>G, and c.-34G>A) previously 
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reported SNPs in the 5′UTR of DEFB103 gene. The association among three diseases and four 
haploid haplotypes was studied. Diploid haplotype analysis shows a trend toward increased risk 
of mastitis (1/4; P= 0.053) in the Saskatchewan population and a decreased risk of mastitis (4/4; 
P= 0.06) in the Pennsylvania population. An inconsistent trend toward decreased (2; P=0.09) or 
increased (4; P=0.09) risk of mastitis also were determined when the haploid haplotypes were 
compared to others in the Saskatchewan and the Pennsylvania populations. There was no 
significant difference in the haplotype frequencies of the control group and cattle with Cancer-
eye (P= 0.43). No significant difference was determined in the survival curve (P=0.50), the level 
of serum haptoglobin (P=0.65), or the level of interferon-gamma (P= 0.50) between cattle with 
diploid haplotypes 2/2 and 2/4 and shipping fever. 
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1.0  GENERAL INTRODUCTION 
Both infectious and non- infectious diseases add significantly to livestock production costs. 
These costs may be related to either decreased growth or productivity, the cost of medical 
treatment, or the culling or death of animals. Genetic selection of animals has been a very 
effective strategy to eliminate single gene diseases, such as beta-mannosidosis (Leipprandt et al., 
1999) in Salers cattle. However, the selection of animals for resistance to infectious disease has 
been much more challenging. Selecting animals that are less susceptible to disease would be one 
approach. Selection pressure on genes involved in the immune system, which is very complex, 
involving both innate and acquired immune responses (Mallard et al., 2014; Thompson-Crispi et 
al., 2014b), could be one strategy. However, genetic selection strategies have focused on both the 
innate and acquired immune systems in Holstein cattle (Thompson-Crispi et al., 2014c). 
Focusing on genes involved in the innate immune system may provide much broader disease 
protection since the innate immune system provides the first barrier of defense against infection. 
Furthermore, a number of innate immune genes, such as TLR4 (Wang et al., 2007), have been 
implicated when analyzing single nucleotide polymorphisms in cohorts of disease resistant or 
susceptible food-producing animals.  
The defensin gene family includes a large number of diverse genes that play multiple roles 
in innate immunity (Lehrer, 2004). The β-Defensin gene members have various antiviral and 
antibacterial activities and diverse gene expression patterns when comparing among different 
tissues. One member of the β-Defensin gene family is β-Defensin 103 (DEFB103). Defensins 
have been widely studied in humans and gene copy number variation (CNV) of DEFB103 has 
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been associated with specific diseases, such as psoriasis (Hollox et al., 2008) and Crohn’s 
disease (Fellermann et al., 2006). Canine studies also reported an association between DEFB103 
and both coat color (Candille et al., 2007) and atopic dermatitis (Santoro et al., 2013).  
The focus of this research was to further characterize the DEFB103 gene in cattle. This 
research included analyzing the number of alleles and their haplotypes and investigating whether 
there were potential associations between DEFB103 gene alleles and haplotypes with two 
infectious and one non- infectious disease. Bovine respiratory disease (shipping fever) and 
mastitis were used as examples of infectious disease, and ocular neoplasia (cancer eye) was used 
as a non- infectious chronic disease. The relevance of these disease studies was further evaluated 
by analyzing tissue-specific expression of the DEFB103 gene and evaluating whether gender or 
infection altered DEFB103 gene expression.  
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2.0  LITERATURE REVIEW 
 2.1  General Review of Gene Structure  
The length of a gene in prokaryotes such as bacteria and some of the lower eukaryotes, 
such as yeast, is equivalent to the size of its protein product. In other words, 3N base pairs of 
DNA sequence encode a protein with N amino acids. Based on many studies of eukaryotic 
genes, such as ovalbumin and immunoglobulin, Gilbert (1978) reported that DNA coding 
sequences are not continuous. Gilbert (1978) introduced the concept of a ‘silent’ DNA sequence 
for the very first time; that interrupts coding sequences. The ‘silent’ DNA sequence became 
known later as introns. DNA sequences that code for a protein are called exons.  
 2.1.1 Promoter region 
The promoter region is the DNA sequence that plays a regulatory role in transcription. 
The promoter sequence provides complementary sites for binding by RNA polymerase enzyme 
and transcription factors that are necessary for transcription (de Vooght et al., 2009). Mammals 
have two types of core promoter sequences, TATA box promoters and CpG island promoter 
motifs (Smale and Kadonaga, 2003; Carninci et al., 2006). The TATA box is usually 25 to 35 bp 
upstream of the start codon (ATG) of an exon, and it determines the direction of transcription 
(Smale and Kadonaga, 2003).  
In CpG islands, cytosine nucleotides are linked to guanine nucleotides by a phosphate 
bond. The length of CpG islands is more than 200 bp (Gardiner-Garden and Frommer, 1987), 
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and about 48% of the potential promoter regions are within CpG islands (Suzuki et al., 2001). 
Gene transcription might be silenced if DNA methylation occurs in this area (Maston et al., 
2006). 
Other regulatory elements in the promoter region may also affect gene transcription. 
These elements are called either an enhancer or a silencer (Maston et al., 2006). Enhancers may 
be far from the transcription start site, about tens of kilobase pairs upstream of the core promoter, 
in an intron or even after the stop codon. Enhancers increase transcription, and their direction or 
distance relative to the transcription initiation site has no effect on their activity (Blackwood and 
Kadonaga, 1998; Maston et al., 2006). Silencers decrease the level of transcription, and most of 
their properties are similar to enhancers. Their sequence provides a binding site for negative 
transcription factors that are called repressors (Maston et al., 2006).  
Mutations can occur in promoter elements, and they may change transcription factor 
binding sites. These kinds of changes could affect gene transcription and make an organism more 
susceptible to disease. It was reported that a 23 bp insertion-deletion polymorphism in the 
putative promoter region of the prion protein gene is associated with bovine spongiform 
encephalopathy (BSE), and individual cattle with an allele including a deletion were more 
susceptible to BSE (Sander et al., 2004; Haase et al., 2007). 
Housekeeping genes such as B-actin and GAPDH are ubiquitously expressed, and they 
are necessary for the maintenance of cell function (Eisenberg and Levanon, 2013). On the other 
hand, some functional genes have a tissue-specific expression (Jacox et al., 2010) or are 
expressed during different developmental periods of an animal’s life (Malmuthuge et al., 2012). 
Malmuthuge et al. (2012) reported that expression of Toll- like receptors was significantly lower 
in the healthy gastrointestinal tract of 6-month dairy calves in comparison to those that were only 
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3 weeks old. Insulin-like growth factor 2 (IGF2) has four alternate promoters in cattle, and they 
generate seven transcripts. Liver is the only tissue with the IGF2 expression for all three 
transcripts that are produced by the first promoter via RNA splicing (Goodall and Schmutz, 
2007). Narciandi et al. (2011) also reported tissue-specific expression for the β-Defensin gene 
cluster on BTA13, in the reproductive tract. 
 2.1.2 RNA splicing 
The transcription product in prokaryotes is called messenger RNA (mRNA), and it is 
ready for translation to protein. However, in eukaryotes, the transcription process generates 
precursor RNA (pre-RNA) that includes exons and introns. In eukaryotes, a couple of steps are 
needed to convert precursor RNA to messenger RNA (mRNA). In one of these steps, introns are 
excluded from precursor RNA and this process is called RNA splicing. RNA splicing occurs in 
the nucleus (Han et al., 2011). A complex, called the spliceosome, is necessary for splicing. It 
includes five uridine-rich small nuclear ribonucleoproteins (snRNPs) along with other specific 
proteins that are involved in binding to the snRNPs (De Conti et al., 2013).  
These snRNPs recognize the exon-intron junction sequences. The U1 snRNP recognizes 
the AG/GU sequence at the 5′ (donor) splice site. A GU pair of nucleotides always occurs at the 
5′ end of introns. An AG pair of nucleotides is prevalent at the 3′ end of exons (Figure 2.1). The 
U2 snRNP recognizes the branch point that is rich in pyrimidine. It is involved in a lariat 
formation that aids in excision of the intron. The U2 Auxiliary Factor (U2AF) recognizes AG/G 
sequence at the 3′ end of the intron, known as the acceptor splice site. AG always occurs at the 3′ 
end of introns, and G is the prevalent nucleotide that exists at the 5′ end of exons (Figure 2.1) 
(McManus and Graveley, 2011; De Conti et al., 2013). In addition to these sequences, other 
regulatory sequences were identified in intronic and exonic regions. They might be enhancer or 
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silencer elements. They are called, exon splicing enhancers (ESEs), exon splicing silencers 
(ESSs), and intron splicing enhancers (ISEs) and intron splicing silencers (ISSs) based on their 
position (McManus and Graveley, 2011). 
 
Figure 2.1: Basic concept of RNA splicing. A schematic picture of a pre-mRNA and the 
prevalent consensus sequences for the 5′ splice site, branch point, and 3′ splice site. 
These enhancer and silencer signals in the exonic and intronic regions are one of the 
regulatory elements of alternative splicing (Goren et al., 2006). In alternative splicing, two or 
more mRNAs are generated from a single pre-RNA. Alternative splicing is usually tissue-
specific, and it is critical in evolution and cell differentiation (McManus and Graveley, 2011). 
Genes with multiple promoters tend to have alternative splicing sites (Xin et al., 2008). IGF2 and 
microphthalmia-associated transcription factor (MITF) are examples of such genes in cattle. 
Alternative splicing has been reported for IGF2 in cattle (Goodall and Schmutz, 2007), pig 
(Amarger et al., 2002), sheep (Ohlsen et al., 1994), human (Holthuizen et al., 1993), rat 
(Holthuizen et al., 1993) and mouse (Holthuizen et al., 1993) (Figure 2.2).  
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Figure 2.2: IGF2 gene structure in different species. Promoters are called by P0–P4. Numbers 
identify IGF2 exons. White boxes represent non-coding exons, and black boxes represent coding 
exons. U1 and U2 in Mouse IGF2 indicate upstream exons 1 and 2 (Goodall and Schmutz, 
2007), reprinted with permission from John Wiley and Sons License Number: 3851061009244. 
 2.1.3 Genotype and Haplotype 
A variant of a gene is called an allele. This variation could be a single nucleotide 
polymorphism (SNP) (Figure 2.3 a), deletion or insertion (Alkan et al., 2011). Depending on the 
type of variation and its position in the coding sequence, it can have a different effect. A 
premature stop codon can be caused by a SNP or a frame shift in amino acid resulting from a 
deletion or insertion. This mutation is called a nonsense mutation (Flanigan et al., 2011). A 
missense mutation is a nucleotide substitution that causes a change in an amino acid in a protein 
(Buchanan et al., 2002). This change might be within a similar group of amino acids, and it is 
then called a conserved mutation. A non-conserved mutation is another type of missense 
mutation in which the new amino acid is from another group (i.e. acidic instead of basic). A 
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silent or synonymous mutation is a nucleotide substitution that causes no change in an amino 
acid sequence. It usually occurs in the third or wobble position of the codon (Komar, 2007). 
 
Figure 2.3: Coding DNA sequences with SNPs, Genotypes, and Haplotypes. a) A coding 
sequence of DNA from three individuals and their homologous chromosome that include three 
SNPs. b) Genotype is a combination of two alleles in a locus on homologous chromosomes. c) A 
haplotype is a combination of alleles from multiple SNPs on a single chromosome.  
Animals have two sets of chromosomes (diploid) (Valero et al., 1992). Therefore, each 
animal carries two alleles of each gene, and this combination is called its genotype (Figure 2.3b). 
A haplotype is a combination of multiple alleles in a particular region of a chromosome (haploid) 
(HapMap, 2003). Each SNP has two alleles, but a particular region of a chromosome might have 
more than two haplotypes based on the various combinations of several genotypes (Figure 2.3c).  
Haplotype data is often used in human population studies to find an association with a 
disease (Trowsdale and Knight, 2013). A genome-wide association study (GWAS) was 
9 
 
conducted by Abdel-Shafy et al. (2014) to test the effect of haplotypes on somatic cell score in 
German Holstein cattle. Ten Haplotypes with significant association (negative or positive) were 
identified in different genomic regions, such as Bos taurus autosome (BTA) 5, 6, 13, 18, 19 and 
X. Huang et al. (2014) studied haplotypes of the IGF2 gene in Chinese Qinchuan cattle. They 
identified 4 SNPs and eight haplotypes among 723 individuals. The mutant haplotype, ATGG, 
showed a significant association with withers height (P = 0.004), and body weight (P = 0.018).  
 2.1.4 Gene orientation 
The direction of a DNA strand is conventionally 5′-3′. The start codon is near the 5′ end 
and the stop codon is near the 3′ end of a gene in the forward orientation. Genes that are in the 
same direction with the DNA strand (5′-3′) are called forward, and those oriented in the opposite 
direction are called reverse (Figure 2.4). Davila Lopez et al. (2010) reported that about 50% of 
neighboring genes have the same orientation in humans.  
The randomness of gene direction in different species was statistically tested by Li et al. 
(2012). This test indicated that gene orientation in at least one of the chromosomes of 99% of the 
tested species is non-random, and all of the chromosomes in archaea and bacteria have non-
random orientation. Fifteen loci in cattle were tested for gene orientation randomness, and 
among these loci, three had non-random gene orientation.  
 
Figure 2.4: A schematic figure illustrating different gene orientation.  
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 2.1.5 Pseudogenes 
Pseudogenes do not code for a protein. A pseudogene is usually derived from a functional 
gene, sometimes called its “parent gene” (Mighell et al., 2000; Pink et al., 2011). Therefore, the 
pseudogene usually has high sequence homology to this “parent” copy, but the occurrence of a 
mutation, such as a premature stop codon or an insertion/deletion, makes the pseudogene unable 
to generate protein (Vanin, 1985; Balakirev and Ayala, 2003). Pseudogenes, like other non-
coding DNA sequences, may have some regulatory role (Balakirev and Ayala, 2003). 
There are two main types of pseudogenes: processed and unprocessed. A processed 
pseudogene is also called a retrotransposon. During the origin of processed pseudogenes, an 
mRNA transcript is reverse transcribed into DNA. This DNA is similar to complementary DNA 
(cDNA) and does not have introns or an upstream promoter sequence (Maestre et al., 1995). 
Duplication generates an unprocessed pseudogene. Cumulative mutations after duplication of a 
gene may interrupt gene function and thus create a pseudogene. Therefore, unprocessed 
pseudogenes have introns and upstream promoter sequence in their structure. An unprocessed 
pseudogene could be a complete copy or a partial copy of a gene (Rouchka and Cha, 2009).  
 2.2  Copy Number Variation (CNV) 
Genomic variations occur in many different forms. Single nucleotide polymorphisms 
(SNPs) are substitution changes in DNA sequence. Variable number tandem repeats (VNTR) 
(Nakamura et al., 1987) are another form of variation that includes microsatellites and 
minisatellites. Microsatellites have 2 to 4 base-pair (bp) of DNA sequence that are repeated 
multiple times, and minisatellites have 10 to 100 bp of repeated DNA sequence (Ramel, 1997).  
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SNPs have been studied more than the other genetic variations. Nevertheless, development 
of sequencing techniques makes it possible for researchers to find microscopic and 
submicroscopic variations in a genome. These structural changes that include deletions, 
duplications, insertions, inversions, and translocations are called copy number variations (CNV) 
(Feuk et al., 2006; Zhang et al., 2009). Most CNVs are segments of DNA of about 1kb to 3 Mb. 
Whereas, structural variations that are smaller than 1kb are usually called small deletions or 
insertions (Feuk et al., 2006).  
Redon et al. (2006) used SNP genotyping arrays, and Whole-Genome Tilepath BAC 
arrays to report a first-generation CNV map of the human genome. They indicated that CNVs 
covered approximately 12% of the human genome, and these sequence variations include a 
greater percentage of the human genome than SNPs. This percentage of CNV coverage is less 
than what Zhang et al. (2009) reported in their review (29.74%). Zhang et al. (2009) defined 
CNV as a DNA segment that is from 100bp to 3 Mb, whereas Redon et al. (2006) defined it as a 
DNA segment larger than 1kb, and also the resolution limitation of methods that were used for 
CNVs detection may cause overestimation.  
Cattle CNVs were identified using array-CGH. In array-CGH, the fluorescence ratio of 
each chromosome is measured to determine locations of deletions and insertions in the test 
samples (Kallioniemi et al., 1992). The existence of cattle CNVs was confirmed by quantitative 
real-time PCR (qRT-PCR) for selected CNVs (Liu et al., 2008). Early estimates for CNV 
coverage in the cattle genome were 0.68% (22 megabases) (Fadista et al., 2010), and 1.07% 
(28.1 megabases) (Liu et al., 2010). Hou et al. (2011) used Bovine HapMap SNP genotyping 
data to estimate CNV regions (CNVRs) in cattle. They reported 682 candidate CNVRs that 
covered 4.6% (139.8 megabases). They reported that about 56% of the CNVRs were associated 
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with about 1263 genes that affect immunity, lactation, reproduction, and rumination. Most of the 
genes with CNV in cattle present in clusters, such as β –Defensins (Gallagher et al., 1995; Elsik 
et al., 2009). 
Btau (Liu et al., 2009) and UMD (Zimin et al., 2009) are two available assemblies for 
cattle reference genome. Fine mapping of copy number variations using high-density BovineHD 
SNP array was performed on both assemblies by Hou et al. (2012). On Btau_4.0 about 3346 
candidate CNVRs were identified that cover about 4.7% (142.7 megabases) of the cattle genome. 
Three thousand, four hundred and thirty eight CNVRs (146.9 megabases) were detected on the 
UMD3.1 assembly. The comparison of these two data sets indicate that UMD3.1 has 50% more 
and 20% longer CNVs. In UMD3.1, most of the unplaced contigs from sequencing were 
assembled, and it might be one of the reasons for this CNV abundance on the UMD3.1 assembly 
(Hou et al., 2012). 
  2.2.1 Mechanisms of CNV formation 
CNVs can be inherited or generated during meiosis (Lupski and Stankiewicz, 2005). A 
recent study using HapMap and analysis of SNPs and CNVs indicated that about 80% of CNV 
differences are between individuals, and more than 99% of those were derived from Mendelian 
inheritance. Based on this information, de novo generation of CNVs is 100 times less than CNVs 
derived from inheritance (McCarroll et al., 2008). Copy number can be different in various 
tissues of an individual (Piotrowski et al., 2008). These findings indicate that CNVs can also be 
generated somatically (Hastings et al., 2009), and as a result, identical twins can have different 
sets of CNVs (Bruder et al., 2008). 
Structural changes in a chromosome happen by homologous and non-homologous 
recombination (Hastings et al., 2009). Duplications, deletions, inversions, insertions and 
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combinations of rearrangements can lead to different copy numbers (Schaschl et al., 2009; Almal 
and Padh, 2012). Two primary mechanisms for CNV formation from these categories are non-
allelic homologous recombination (NAHR) and non-homologous end joining (NHEJ) 
(Stankiewicz and Lupski, 2010).  
 2.2.2 Variation in copy number and disease susceptibility 
CNV studies in different species revealed that the number of copies for a particular gene 
had an association with complex and common disorders. CNVs can have effects on disease in 
various ways such as gene dosage (Schaschl et al., 2009), gene interruption (Vincent et al., 
2000), gene fusion (Woodwark and Bateman, 2011), and position effects (Henrichsen et al., 
2009).  
The peripheral myelin protein 22 (PMP22) gene expression is affected by gene dosage. 
PMP22 is located in a 1.5 Mb duplication/deletion region on the short arm of chromosome 17 in 
humans. Charcot-Marie-Tooth peripheral neuropathy phenotype is linked to this area. 
Duplication of this locus causes PMP22 overexpression and the manifestation of Charcot-Marie-
Tooth disease in humans. On the other hand, deletion of this locus causes haplo insufficiency and 
PMP22 under expression that increases hereditary neuropathy with liability to pressure palsies in 
humans. The deletion of 1.5 Mb includes 30 to 50 genes, but the PMP22 gene is the only gene 
that shows a gene effect dosage (Lupski, 1998).  
Another example of gene dosage is Parkinson's disease in humans. Parkinson's disease is 
one of the most common nervous disorders. It can affect approximately 1% of people over 50 
years old (Polymeropoulos et al., 1996). Singleton et al. (2003) reported a triplication of the 
SNCA gene, located on 4q21, in a large family with autosomal dominant early-onset Parkinson's 
disease. The triplicated region size is about 2 Mb and includes the whole SNCA gene and 17 other 
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genes. Patients with SNCA duplication or triplication show different Parkinson's disease 
phenotypes. Duplication of SNCA causes classical Parkinson's disease while patients with the 
SNCA triplication have more severe phenotypes (Singleton et al., 2013). Therefore, SNCA copy 
number has a gene dosage effect on Parkinson's disease phenotypes.  
Red-green color blindness in humans is an example of gene interruption. The red and 
green pigment genes have high sequence homology (98%) (Nathans et al., 1986). Therefore, they 
tend to have crossing over, and this can cause a series of duplications and deletions in these genes.  
Many studies were conducted to show the β-Defensins CNV and their association with 
Crohn’s disease in humans. Fellerman et al. (2006) reported that individuals with 3 or fewer 
copies of DEFB4 (HBD2) are more susceptible to colonic Crohn’s disease. Also, individuals with 
fewer copies of DEFB4 had significantly (P = 0.033) lower mucosal mRNA expression. 
However, this association is in contradiction with the study by Bentley et al. (2010). They 
revealed that individuals with 4 or more copies of DEFB4 were more susceptible to colonic 
Crohn’s disease. One of the reasons for this contradiction might be their sample size. Fellerman et 
al. (2006) tested ten patients with Crohn’s disease and ten controls. While, Bentley et al. (2010) 
examined 466 patients with Crohn’s disease and 329 controls. 
Unlike humans, fewer studies have been conducted in livestock to find an association 
between CNVs and diseases. Twenty CNVs were identified in cattle selected for resistance or 
susceptibility to intestinal nematodes (Liu et al., 2011). Liu et al. (2011) revealed that two main 
events occurred in a region that was related to ATP-binding cassette sub-family C member 
4 (ABCC4), also known as the multidrug resistance-associated protein 4 (MRP4) gene. The 
expression of ABCC4I gene was up-regulated 14 days after Cooperia oncophora infection (Li 
and Gasbarre, 2009).  
15 
 
Hollox et al. (2008) suggested a model for the relation of CNV and the disease 
Succeptibility. “Increasing copy number increases susceptibility to inflammatory or autoimmune 
disease, but increases protection against infectious disease. Decreasing copy number increases 
susceptibility to infectious disease but decreases susceptibility to inflammatory or autoimmune 
disease”. 
 2.3 Defensins and Innate Immunity 
Mammalian species are exposed to a wide variety of pathogenic and non-pathogenic 
micro-organisms. It is critical that host species discriminate between non-pathogenic micro-
organisms, such as the commensal bacteria present on all body surfaces, and pathogenic micro-
organisms that breach external barriers and establish an infection. Mammalian species have 
developed a variety of ways to protect themselves from these infectious agents, and collectively 
these protective mechanisms comprise the immune system. The immune system has been 
functionally divided into innate and adaptive immune responses (Kimbrell and Beutler, 2001) 
but it is now known that both arms of the immune system are functionally integrated and work in 
concert to prevent or clear microbial infections (Mantovani et al., 2011; Zak and Aderem, 2015).  
All living organisms have an innate immune system (Kimbrell and Beutler, 2001) which 
is characterized by rapid activation within a short time following infection (Hazlett and Wu, 
2011). The first line of defense in the innate immune system is a physical barrier, such as skin 
and mucosal surfaces. Chemical barriers such as antimicrobial peptides are produced by cells 
within the epithelial layer and provide a second line of defense. Antimicrobial peptides can act 
against a wide variety of pathogens (Agerberth and Gudmundsson, 2006). If, however, a 
pathogen evades this first layer of defense then innate immune cells can be recruited to control 
the pathogen replication. A wide variety of innate immune cells, including macrophages, 
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neutrophils, dendritic cells (DCs), and natural killer (NK) cells may be recruited. Antimicrobial 
peptides may play a role in the recruitment of these cells (Yang et al., 2002; Lai and Gallo, 2009) 
and cells, such as DCs then play a key role in linking the innate and adaptive immune system 
(Yang et al., 1999; Luster, 2002). 
The adaptive immune response is present only in vertebrates (Pancer and Cooper, 2006). 
This system provides a response that is unique to individual proteins within pathogens and 
following initial exposure to a pathogen this first response may result in the activation of specific 
B cells and T cells. Furthermore, this activation of specific B and T cells can result in prolonged 
survival of these cells, which has been characterized as immune memory. This immune memory 
then facilitates a more rapid and stronger immune response following re-exposure to the same 
pathogen (Bonilla and Oettgen, 2010). This immune memory may then facilitate a much more 
rapid clearance of the pathogen following a secondary invasion or infection.  
 2.3.1 Antimicrobial peptides in innate immunity 
Antimicrobial peptides are produced in mammals, insects, and plants and provide an 
important defense mechanism of the innate immune system (Lehrer and Ganz, 1992). These 
small polypeptides consist of fewer than 100 amino acids (Ganz, 2003a), and their production is 
highest in tissues and cells that provide a significant barrier to commensal and pathogenic 
microbes. Among these tissues, epithelial surfaces are the most important sites for the production 
of antimicrobial peptides in vertebrates, invertebrates, and plants (Ganz, 2003a; Ganz, 2003b). 
Defensins (Ganz et al., 1985; Selsted et al., 1985) and cathelicidins (Zanetti et al., 1995; Lehrer 
and Ganz, 2002) are the two major families of antimicrobial peptides in humans and other 
mammals. Defensins are highly expressed in mammalian epithelial tissues (Pazgier et al., 2006). 
Cathelicidins share some similarities with defensins in their sites of expression and their quantity 
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but they are structurally and evolutionary distinct (Zanetti et al., 1995; Lehrer and Ganz, 2002). 
Other antimicrobial peptides, including histatins (Tsai and Bobek, 1998) and Dermcidin 
(Schittek et al., 2001), are also present in mammals, but their presence is limited to specific 
animal species and tissues. Dermcidin expression was limited to sweat glands (Schittek et al., 
2001). Expression of histatins was limited to the parotid and submandibular salivary glands in 
humans (Tsai and Bobek, 1998) and the old world Rhesus monkey (Macaca mulatta) but was not 
detected in mice (Dickinson et al., 1987).  
 2.3.2 Defensin gene family 
Defensins are an important family, of antimicrobial peptides produced in both animals 
and plants (Thomma et al., 2002). Defensins are part of the innate host defenses that protect 
against infection by Gram-positive and Gram-negative bacteria, mycobacteria, fungi, and 
enveloped viruses when their concentration is 1-100 μg/ml (Ganz and Lehrer, 1995). Defensins 
are small arginine-rich cationic peptides (3-4 kDa). These small peptides, 16-50 amino acids, 
have a β-sheet rich folding (Ganz and Lehrer, 1995; Reddy et al., 2004; Jarczak et al., 2013). The 
first antimicrobial peptides identified with a beta-sheet structure were isolated from rabbit 
macrophages and antimicrobial peptides with a similar structure were then called defensins 
(Boman, 1995). This class of molecules is also characterized by three intramolecular disulfide 
bonds (six linked cysteines) (Reddy et al., 2004; Jarczak et al., 2013). 
Peptide length, linking pattern of the conserved cysteine bonds, the site of protein 
production (Lehrer and Ganz, 1999; Ganz, 2003a), and tertiary structure (Ganz, 2003a; Selsted, 
2004) are criteria used to separate defensins into α-, β- (Lehrer and Ganz, 1999) and θ-defensin 
(Tang et al., 1999; Selsted, 2004) subfamilies. It is argued that the α- and β-defensin families 
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arose from a common pre-mammalian gene based on their chromosomal location in humans 
(8p22-8p23), gene structure, and similar peptide precursors (Liu et al., 1997). 
The α-defensins are also called “common classic defensins” with each member consisting 
of 29-35 amino acids (Jarczak et al., 2013). For α-defensins, the six conserved cysteines create 
three disulfide bonds between 1-6, 2-4, and 3-5 (Ganz, 2003a) and α-defensins are only 
expressed in mammals and marsupials. Therefore, they may have evolved before the divergence 
of placental mammals and marsupials (130 million years ago) (Lynn and Bradley, 2007). The 
presence of α-defensins has been reported in many mammalian species, including humans (Ganz 
and Lehrer, 1995), rabbits, guinea pigs (Jarczak et al., 2013), and the horse (Bruhn et al., 2007). 
It has been suggested that cattle (Bos taurus) do not express α-defensins. This conclusion is 
based on a search of GenBank sequences (Fjell et al., 2008; Zimin et al., 2009) and genome 
analysis (Lynn and Bradley, 2007) that did not reveal sequences homologous to human α-
defensins. Cattle have a gene cluster containing 11 cathelicidins, but α-defensins genes are 
absent from this cluster. In contrast, humans and mice have multiple α-defensins but only a 
single cathelicidin gene (Zanetti, 2004).Therefore, cathelicidins may replace the function of α-
defensins in cattle.  
θ -Defensins are the most recent member of the defensin gene family. They contain 18 
amino acids (Selsted, 2004). Six θ-defensin genes were reported in humans, chimpanzees, and 
gorillas, but all of them are pseudogenes because of the same premature  stop codon mutation. 
However, functional θ-defensin genes were reported in some old world monkeys, such as 
Hylobates syndactylus (a lesser ape) and orangutans (Nguyen et al., 2003). The θ-defensins arose 
from the post-translational splicing of two α-defensin precursors and are only expressed in 
leukocytes of nonhuman primates (Tang et al., 1999; Nguyen et al., 2003; Selsted, 2004).  
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  2.3.2.1 The β-Defensin subfamily 
β -Defensins contain 38-50 amino acids (Jarczak et al., 2013). In the β –Defensin family, 
the six conserved cysteines create three disulfide bonds between cysteines 1-5, 2-4, and 3-6 
(Ganz, 2003a). Based on phylogenetic analyses, β-defensins are older than α-defensins (Lehrer 
and Ganz, 1999). Previous studies have shown that most β-defensins are located within a single 
gene cluster. The location of the β-defensin gene cluster is on chromosome 8 in humans (Bevins 
et al., 1996; Pazgier et al., 2006) and on chromosome 16 in dogs (Patil et al., 2005). In cattle, 
three β-defensin clusters are present on chromosomes 27 (BTA27) (Gallagher et al., 1995) 
(Figure 2.5), BTA13 (Cormican et al., 2008) and BTA23 (Meade et al., 2014). Based on 
available data in GenBank, ten members of the β-defensin gene family are present on BTA27. 
The size of this gene cluster is about 1.3 Mbp (Figure 2.5). The β-defensin cluster on 
chromosome 27 shows copy number variation (Meade et al., 2014). There is another cluster of 
beta-defensins on BTA13 that contains 19 members (Cormican et al., 2008), and five members 
(DEFB110, DEFB111, DEFB112, DEFB113, and DEFB114) are on BTA23 (Meade et al., 
2014). Genomic approaches and bioinformatic studies of the bovine genome created an 
opportunity to identify more β-Defensin genes in cattle. Cattle, with 57 β-Defensin genes, have 
the largest number of β-Defensin genes among vertebrates (Meade et al., 2014). As mentioned 
earlier, there are no α-Defensin genes in cattle (Fjell et al., 2008; Zimin et al., 2009). Therefore, 
the greater number of genes in the β-Defensin family may compensate for the lack of α-
Defensins. 
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Figure 2.5: β-defensin gene cluster on chromosome 27 in cattle.  
Tracheal antimicrobial peptide (TAP), the first defensin that was identified in cattle, has a 
broad spectrum of activity against fungi (Candida albicans), Gram-positive (Staphylococcus 
aureus), and Gram-negative (Escherichia coli) bacteria (Diamond et al., 1991). TAP is expressed 
in the respiratory mucosa in higher levels than lung tissue (Diamond et al., 1991), and its 
expression is up-regulated by bacterial infection (Diamond et al., 2000). TAP has been shown to 
have antimicrobial activity against Staphylococcus aureus, but TAP expression decreased when 
bovine mammary epithelial cells were infected with live S. aureus (Lopez-Meza et al., 2009). 
This observation may provide one explanation for how S. aureus evades innate immunity and 
remains the most common cause of chronic mastitis in cattle (Fox, 2012). 
The next group of β-defensin peptides were isolated from cattle neutrophils (Selsted et 
al., 1993) and included DEFB4 and DEFB5 (Ryan et al., 1998). Ryan et al. (1998) reported that 
DEFB4 and DEFB5 were highly expressed in bovine alveolar macrophages. In contrast to TAP, 
DEFB4 and DEFB5 expression was up-regulated in both cistern and alveolar tissues of cattle 
mammary glands that were infected with S. aureus (Whelehan et al., 2011). This may reflect the 
recruitment of macrophages following bacterial infection.  
The human β-defensin 3 (hBD-3) or DEFB103 is another member of the β-defensin 
family. Harder et al. (2001) isolated and characterized hBD-3 protein from human psoriatic 
21 
 
scales. The hBD-3 has antimicrobial activity against Gram-positive bacteria (S. aureus, 
multiresistant S. aureus, and Streptococcus pyogenes), Gram-negative bacteria (Pseudomonas 
aeruginosa and E. coli), and the yeast Candida albicans (Harder et al., 2001). Harder et al. 
(2001) observed the interaction of hBD-3 and S. aureus under transmission electron microscopy 
to understand how hBD-3 reacts to S. aureus. They realized that hBD-3 creates a perforation in 
the peptidoglycan cell wall of S. aureus in the exact same way that penicillin does as an 
antibiotic. This characteristic distinguishes hBD-3 from other defensins that create folded 
(mesosome-like) structure in a cell membrane (Shimoda et al., 1995). 
Candille et al. (2007) reported that CBD103 (DEFB103 ortholog in dogs) binds to the 
melanocortin 1 receptor (MC1R) and effects pigment type-switching in domestic dogs and 
transgenic mice. They also reported that CBD103 binds to melanocortin 4 receptor (MC4R) in 
mice and it causes feeding behavior suppression.  
 2.3.2.2 β-Defensin immunomodulatory activity 
Linking innate and adaptive immune responses is critical for a coordinated host defense 
against infectious agents (Medzhitov and Janeway, 2000). In this situation, the innate immune 
system senses the danger of infection and informs the adaptive immune system to respond to this 
threat. The β-defensin antimicrobial peptides have a significant immunomodulatory effect, in 
addition to their direct antimicrobial role. A number of studies indicate that β-defensins play an 
important role in linking innate and adaptive immune responses (Yang et al., 1999; Hammad and 
Lambrecht, 2008). 
Phagocytic cells, such as DCs (dendritic cells) and macrophages, can present antigen to T 
lymphocytes and induce an antigen-specific response (Sallusto and Lanzavecchia, 2002; Kabelitz 
and Medzhitov, 2007). Immature DCs and memory T cells express the CCR6 chemokine 
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receptor, which binds human β-defensins (hBDs). Therefore, hBDs can be chemotactic for these 
cells and recruit them to sites of infection (Yang et al., 1999). The hBD3 also bind to periodontal 
pathogens like P. gingivalis hemagglutinin B. This can reduce the cytokine stimulation because 
pathogen does not attach to the keratinocytes or DCs. This can improve the adaptive response 
and control the inflammation in the oral cavity (Diamond and Ryan, 2011). Garcia et al. (2001) 
reported that hBDs could function as a chemoattractant for monocytes but the specific receptor 
involved is not known.  
Toll- like receptors (TLRs) are a well-characterized family of innate immune receptors 
expressed on a broad range of innate immune cells. TLRs play an important role in regulating 
both the innate and adaptive immune responses through activation and maturation of dendritic 
cells (Kabelitz and Medzhitov, 2007). Funderburg et al. (2007) reported that hBD-3 may be able 
to link the innate and adaptive immune system through TLR signaling. Recombinant hBD-3 was 
used to demonstrate a direct interaction with TLR1 and 2. The expression of a cluster of 
differentiation genes, such as CD80, CD86, and CD40, was increased following stimulation of 
myeloid DCs and monocytes with recombinant hBD-3.  
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3.0  TISSUE AND AGE-DEPENDENT EXPRESSION OF THE BOVINE 
DEFB103 GENE AND PROTEIN 1,2 
 3.1  Abstract 
Beta-defensin 103 (DEFB103) shares little homology with nine other members of the bovine 
beta-defensin family on BTA27, and in other species DEFB103 protein has diverse functions, 
including antimicrobial activity, a chemoattractant for dendritic cells, enhancing epithelial 
wound repair and regulating hair color. Expression of the bovine DEFB103 gene was surveyed 
in 27 tissues and transcript was most abundant in tissues with stratified squamous epithelium. 
Oral cavity epithelial tissues and nictitating membrane consistently expressed high levels of 
DEFB103 gene transcript. An age-dependent decrease (P <0.05) in DEFB103 gene expression 
was only observed in buccal epithelium when comparing healthy 10- to 14-day-old and 10- to 
12-month-old calves. A bovine herpesvirus-1 respiratory infection did, however, significantly (P 
< 0.05) up-regulate DEFB103 gene expression in the buccal epithelium of 6- to 8-month-old 
calves. Finally, DEFB103 transcript was low in lymph nodes draining the skin and at the limit of 
detection in other internal organs such as lung, intestine, and kidney. Affinity-purified rabbit 
antisera to bovine DEFB103 was used to identify cells expressing DEFB103 protein within 
                                                 
1 A version of this chapter has been published: Mirabzadeh-Ardakani, A., Solie, J., Gonzalez-
Cano, P., Schmutz, S.M. and Griebel, P.J. Tissue- and age-dependent expression of the 
bovine DEFB103 gene and protein. Cell Tissue Res 363 (2016), pp. 479-90. 
 
2 The immunohistochemistry section in this chapter was conducted by Jay Solie, a summer 
student in the lab of Philip Griebel.  
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tissues with stratified squamous epitheliums. DEFB103 protein was most abundant in basal 
epithelial cells and was present in these cells prior to birth. Beta-defensins have been identified 
as regulators of dendritic cell (DC) chemokine responses, and we observed a close association 
between DCs and epithelial cells expressing DEFB103 in both the fetus and newborn calf. In 
conclusion, bovine DEFB103 gene expression is most abundant in stratified squamous 
epithelium with DEFB103 protein localized to basal epithelial cells. These observations are 
consistent with proposed roles for DEFB103 in DC recruitment and repair of stratified squamous 
epithelium. 
 3.2  Introduction 
Antimicrobial peptides, also known as host defense peptides, are an important component 
of the innate immune system (Cederlund et al., 2011). They include several families of 
structurally diverse molecules, consisting of less than 100 amino acids, and perform diverse 
functions, including both direct antimicrobial activity and modulation of innate immune 
functions (Ganz and Lehrer, 1994). The expression of antimicrobial peptides is highest in tissues 
and cells that provide an important barrier to commensal and pathogenic microbes, and this 
expression pattern is conserved among vertebrates, invertebrates, and plants (Ganz, 2003b; Ganz, 
2003a).  
Defensins are one family of antimicrobial peptides produced in mammals that share 
structurally similar motifs (Boman, 1995). They are 3- to 4-kDa cationic proteins with six 
conserved cysteine residues that create three cysteine–disulfide bonds (Ganz and Lehrer, 1994). 
Three different patterns of disulfide bonding among the conserved cysteines divides the defensin 
family into α-, β-, and θ-defensin subfamilies (Ganz and Lehrer, 1994; Lehrer and Ganz, 1999; 
Tang et al., 1999). The three cysteine–disulfide bonds of α-defensins are created by connecting 
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C1 to C6, C2 to C4, and C3 to C5 (Ouellette and Selsted, 1996), and cysteine cross- linking in β-
defensins is C1 to C5, C2 to C4, and C3 to C6 (Tang and Selsted, 1993). In contrast, cyclic 
cysteine–disulfide bonds are created in the θ-defensin subfamily by connecting C1 to C6, C2 to 
C5, and C3 to C4 (Tang et al., 1999).  
Based on phylogenetic analyses, β-defensins are older than α-defensins, and θ-defensins 
arose from two mutants of α-defensin genes in primates (Tang et al., 1999). A number of β-
defensin genes are expressed in mammals, birds, and reptiles (Lehrer, 2004; Patil et al., 2004; 
Bagnicka et al., 2010) and most β-defensins occur within a single gene cluster. The β-defensin 
gene cluster is located on human chromosome 8 (Bevins et al., 1996; Pazgier et al., 2006), dog 
chromosome 16 (Patil et al., 2005), and cattle chromosomes 27 and 13 (Gallagher et al., 1995; 
Cormican et al., 2008). The genomic structure of most of the β-defensins consists of two exons 
and one intron. DEFB105 has three exons and two introns (Pazgier et al., 2006), and a new non-
coding exon has been reported in the 5′UTR of bovine β-defensin 103 (DEFB103) and also 
predicted in ovine and caprine DEFB103 (Mirabzadeh-Ardakani et al., 2014a). DEFB103 has the 
lowest amino acid homology when comparing the structure of mature peptides within the bovine 
β-defensin family (Figure 3.1a), and there is a relatively low level of homology when comparing 
DEFB103 among different species (Figure 3.1b). Therefore, this β-defensin may possess 
biological activities distinct from other β-defensin family members both within and among the 
different species.  
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Figure 3.1: Amino acid alignment for β-defensins. a) Amino acid alignment for the β-defensin 
gene family on cattle BTA27. Asterisks indicate the six conserved cysteine amino acids. Bold 
letters indicate that all β-defensins have the same amino acid in the indicated position except 
DEFB103. Underlined letters show that 5 or more members of β-defensin gene family share the 
same amino acid in the indicated position, but it is not similar to DEFB103. Arrows indicate the 
two epitopes chosen to raise antisera for immunohistochemistry. b) DEFB103 amino acid 
alignment among different species. The first 22 amino acids (bold and underlined) in DEFB103 
indicate the signal peptide. 1 and 2 show the start of the two coding exons. Underlined letters 
show that 5 or more members of the β-defensin gene family share the same amino acid in that 
position, but it is not similar to bovine DEFB103.  
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DEFB103 gene copy number variation has previously been reported with 2-12 gene copies 
per diploid genome identified in human (Hollox et al., 2003) and 2-4 gene copies per diploid 
genome reported for dogs (Leonard et al., 2012). A higher genomic copy number of β-defensin 
genes has been linked to a greater susceptibility to psoriasis (Hollox et al., 2008), and individuals 
with a lower human β-defensin-2 gene copy number also have a reduced transcript abundance 
(Fellermann et al., 2006). The bovine DEFB103 gene also occurs in multiple copies in at least 
some individuals, based on sequence results from a cloning experiment (GenBank KM347983, 
KM347984, KM347985, and KM347986), and Reverse Transcription PCR (RT-PCR) data 
(Mirabzadeh-Ardakani et al., 2014a) but nothing is known regarding bovine DEFB103 gene 
expression in specific tissues or whether expression is developmentally regulated or altered 
during an infection. Many epithelial tissues, particularly skin, express β-defensins (Pazgier et al., 
2006; Candille et al., 2007; Leonard et al., 2012). Canine DEFB103 gene (CBD103) expression 
was greatest in the tongue and was the most abundant β-defensin gene transcript detected in the 
skin (Leonard et al., 2012). Human DEFB103 gene expression was detected in a wide variety of 
tissues, including oral epithelium, lung, trachea, skin, and neutrophils (Pazgier et al., 2006). 
Cross-reactive antisera to human β-defensin 103 (hBD-3) revealed detectable levels of CBD103 
protein within epithelial cells located in the canine skin and around hair follicles (Leonard et al., 
2012). In the present investigation, we hypothesised that bovine DEFB103 gene expression was 
also restricted primarily to tissues containing epithelial cells. Real-Time Quantitative Reverse 
Transcription PCR (Real-Time qRT-PCR) was used to complete a broad survey of bovine 
tissues, and this analysis confirmed that tissues with stratified squamous epithelium had a 100- to 
1000-fold higher level of DEFB103 transcript. We then investigated whether expression of the 
DEFB103 gene in epithelial tissues was altered by age, sex, or a viral respiratory infection. 
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Finally, immunohistochemistry (IHC) was used to determine if the production of DEFB103 
protein was restricted to a particular subpopulation of the epithelial cell. This analysis confirmed 
that DEFB103 protein was produced primarily in basal epithelial cells and revealed a close 
association between dendritic cells and cells expressing DEFB103. 
 3.3 Materials and Methods 
 3.3.1 Tissue collection for RNA extraction 
All experimental protocols for animals were reviewed and approved by the University of 
Saskatchewan Committee on Animal Care following guidelines approved by the Canadian 
Council on Animal Care. Calves were euthanized with an intravenous injection of 20 mL/45 kg 
Euthanyl (Bimeda-MTC, Canada) and all tissues for RNA extraction were collected within 15–
30 minutes post-mortem. Tissues sampled included skin (lateral aspect of shoulder, axillary 
region, and perianal), blood (both peripheral blood mononuclear cells (PBMC) and 
polymorphonuclear cells (PMNs) were isolated separately (Whale et al., 2006)), tongue 
epithelium, buccal epithelium, tracheal mucosa, lung parenchyma, rumen, jejunum, ileum, 
caecum, rectum, testes, nictitating membrane (third eyelid), liver, spleen, kidney, bladder, 
adrenal gland, superficial cervical lymph node, skeletal muscle (shoulder), cardiac muscle, 
abomasal muscle, perirenal fat, and spinal cord. Tissues were collected from healthy 10- to 14-
day-old male Holstein calves (n=9). To determine whether gender or a respiratory infection 
altered DEFB103 gene expression tissue samples were obtained from the tongue and buccal 
epithelium of five male and five female 6- to 8-month-old Angus-cross beef calves 14 days after 
an experimental challenge with bovine herpesvirus-1 (BHV-1). A group of four castrated male 
calves, between 10 and 12 months of age, were used as uninfected controls for the collection of 
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the tongue and buccal epithelium. Calves between 6 and 12 months of age represent sexually 
immature animals. Details of the BHV-1 challenge study have been published by Griebel et al. 
(2014) and tissues were collected on day 14 post-BHV-1 infection. At this time, BHV-1 infection 
is being cleared (Griebel et al., 2014) and innate immune defenses, especially those involved in 
the repair of epithelium, may be activated. To determine whether age altered DEFB103 gene 
expression, tissue samples were collected from the tongue, buccal epithelium, skin (shoulder), 
and rumen of four healthy, castrated male 10- to 12-month-old Holsteins. For the analysis of 
DEFB103 gene expression, several 2-3 mm2 pieces of tissue were immersed in 1 ml RNAlater® 
(Applied Biosystem-Ambion) and kept overnight at room temperature before storing samples at 
−80 C until RNA was extracted. 
 3.3.2 Tissue collection for Immunohistochemistry  
Approximately 5 mm2 sections of nictitating membrane, buccal epithelium, rumen, 
shoulder skin, and bladder were collected following euthanasia of five 10- to 14-day-old, male 
Holstein calves and three fetal calves collected by caesarean section during the last trimester of 
gestation. Tissue samples were placed with the epithelial surface supported by a 3- to 4-mm-
thick section of fresh liver placed on a strip of acetate film. Tissue blocks were slowly immersed 
in liquid N2 to snap-freeze and then stored in sealed cryovials at −80°C.  
 3.3.3 RNA extraction 
Total RNA was extracted from tissues stabilized by RNAlater® using the TRIzol method 
(Invitrogen). Tissue fragments were homogenized in TRIzol solution by using a bead beater. 
Extracted RNA was treated with DNase-I (RNase-free; Invitrogen) to remove DNA, and RNA 
quantity and quality were then determined using a NanoDrop 2000 (NanoDrop Technologies, 
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DE, USA) spectrophotometer following the first extraction and an Agilent 2100 Bioanalyzer 
(G2938B; Agilent Technologies, Mississauga, Ontario, Canada) following the second RNA 
extraction. RNA with an RNA integrity number higher than 7 was considered acceptable for 
cDNA preparation. 
 3.3.4 Real-Time qRT-PCR primer design and validation  
A primer pair for DEFB103 (GenBank EU715240.1) was designed using the Clone 
Manager 9.0 program (Sci-Ed Software): forward primer 5'-CTTGTTCTTGCTGCCTGTTC-3' 
in exon 1; reverse primer 5'-GCCTATCTGTTCCTCCTTTG-3' in exon 2. A single copy of the 
DEFB103 gene was cloned into a plasmid to determine the amplification efficiency of the primer 
pair. The linear range of amplification was determined by using serial dilutions of plasmid 
between 3 X 100 to 3 X 105 molecules. A standard curve (Appendix A) was drawn, and a linear 
regression equation was determined using Excel. Exponential amplification (Eq. 3.1) and 
efficiency percentage (Eq. 3.2) (Nolan et al., 2006) were calculated to evaluate amplification 
efficiency. 
                                            (Eq. 3.1) 
                                       (Eq. 3.2) 
The calculated exponential amplification for the DEFB103 primer pair was 2.03, with a 
calculated efficiency of 103.5%. B-actin (GenBank AF191490) was used as a housekeeping gene 
and the primer pair used (forward primer 5'-AGGCATCCTGACCCTCAAGTA-3'; reverse 
primer 5'-GCTCGTTGTAGAAGGTGTGGT-3') was previously validated for both specificity 
and amplification efficiency (Charavaryamath et al., 2011). B-actin efficiency was 101% and it 
was similar to the DEFB103 primer pair efficiency. 
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 3.3.5 cDNA synthesis and Real-Time qRT-PCR of cattle DEFB103 
Total RNA (250 ng) was reverse-transcribed using qScriptTM cDNA SuperMix (Quanta 
BiosciencesTM), following the manufacturer’s protocol. The cDNA was diluted 1:10 using 
UltraPure™ DNase/RNase-Free Distilled Water (Invitrogen) and then used as a template for the 
Real-Time qRT-PCR. Real-Time qRT-PCR was performed using PerfectaTM SYBR® Green 
SuperMix for iQTM (Quanta Biosciences), following the manufacturer’s protocol. The primer 
pair was used to amplify a 124-bp fragment of DEFB103 that included part of both DEFB103 
coding exons and flanked the intervening intron. A single product was amplified, and the product 
was sequenced to confirm identity with DEFB103. 
 3.3.6 Generation of DEFB103 Antisera and Immunohistochemical staining of tissues  
To validate the Real-Time qRT-PCR analysis of DEFB103 gene expression in newborn 
calves and identify cells producing DEFB103 protein, a rabbit polyclonal antisera was 
commercially produced by Pierce Custom Services (Thermo Fisher Scientific). Two epitopes 
were designed and synthesized (Pierce Custom Services) to include amino acids 46-55 
(LPKEEQIGRC) and 56-67 (SLSGRKCCRKKK) located near the C-terminus of the mature 
bovine DEFB103 protein (Figure 3.1a). The criteria used to select these two epitopes were 
predicted immunogenicity (Pierce Custom Services) and a comparison of amino acid sequences 
among known bovine β-defensins on BTA27. This comparison was completed using sequences 
with following accession numbers: DEFB103 (NP_001108334.1); LAP (NP_982259.3); TAP 
(NP_777201.1); DEFB10 (NP_001108556.1); DEFB4 (NP_777200.1); DEFB7 
(NP_001095832.1); DEFB5 (NP_001124233.1); DEFB402 (CAD91246.1); and DEFB1 
(NP_783634.1) (Figure 3.1a). Conservation of the bovine DEFB103 amino acid sequence among 
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species was also analyzed using the following accession numbers: cattle DEFB103; 
ACH69778.1; horse DEFB103; CAJ01801.1; pig DEFB3; NP_999609.1; dog CBD103; 
AAY59710.1; human HBD3: NP_061131.1; chimpanzee DEFB103; NP_001123222.1; mouse 
DEFB14: AAI16200.1; chinchilla DEFB1: AAM97293.1; opossum DEFB103: XP_001381623.1 
(Figure 3.1b). 
To generate specific antisera to bovine DEFB103, two rabbits were immunized with either 
peptide 46–55 or peptide 56–67 (Figure 3.1a) conjugated to KLH. The rabbits were bled 
monthly, and antibodies specific for each peptide were detected by ELISA, using the 46-55 and 
56-67 peptides to capture antibodies. Rabbit immunizations were repeated over a 6-month period 
until a high titre of antibody specific to the 46-55 peptide was consistently detected. ELISA 
never detected specific antibodies to the 56-67 peptide. Immunoglobulin G (IgG) was then 
purified by ammonium sulfate precipitation from the serum of the rabbit with the highest 
antibody titre to the 46-55 peptide. Purified IgG was then passed through an affinity column with 
conjugated 46-55 peptide (Pierce Custom Services). Specificity of the eluted IgG was again 
confirmed by ELISA, using the 46-55 peptide to capture IgG. This procedure generated affinity-
purified IgG with a 46-55 peptide-specific titre exceeding 10,000 (inverse of IgG dilution giving 
a positive reaction in the ELISA). This affinity-purified rabbit IgG was then used for the bovine 
DEFB103 IHC studies.  
Cryosectioning of frozen tissues and staining of cryosections were performed as described 
previously (Griebel et al., 1992). IHC staining with the affinity purified DEFB103-46-55 rabbit 
antisera was optimized using a Vectastain Elite ABC kit (Pierce) to visualize antibody binding. 
The rabbit anti-bovine DEFB103 antisera was titrated to identify the highest dilution (0.07 g 
IgG/ml) that gave visible staining and an affinity-purified rabbit antisera to an irrelevant protein 
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(human CCR5; Sigma Aldrich) was used at the same concentration to control for non-specific 
antibody binding. The anti-CD205 monoclonal antibody was previously optimized for IHC 
staining of bovine tissues (Fries et al., 2011) and validated for reactivity with bovine DCs 
(Gonzalez-Cano et al., 2014). 
 3.3.7 Statistical analysis 
All Real-Time qRT-PCR reactions were repeated in duplicate for each sample, and 
average values used for subsequent analyses. Tissues expressing DEFB103 with cycle threshold 
(Ct) below 35 were considered positive and included in subsequent analyses. A one-way 
ANOVA with Tukey’s post hoc analysis was used to determine which tissues had significantly 
different transcript abundance when comparing samples from either 10- to 14-day-old Holstein 
calves (n=9) or 6- to 8-month-old Angus calves following BHV-1 respiratory infection and to 
examine the effects of gender and infection. Student’s t-test was used to analyse the effect of age 
on DEFB103 transcript abundance within individual tissues.  
3.4  Results 
 3.4.1 Comparison of DEFB103 gene expression in tissues collected from newborn calves 
To determine whether -actin was an appropriate house-keeping gene for the comparison 
of DEFB103 transcript abundance in multiple tissues and animals, we first compared Ct values 
for -actin among all tissues surveyed. This comparison revealed consistent -actin expression 
levels in all tissues (mean + SEM = 21.1 + 0.16) with the exception of rumen (mean + SEM = 
20.5 + 0.13) where-actin transcript was significantly (P < 0.05) more abundant. The difference 
in -actin transcript abundance in the rumen was less than one Ct, which could, however, result 
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in an underestimation of DEFB103 transcript abundance in the rumen. Consistent -actin 
transcript abundance in all other tissues, regardless of age, gender or viral infection provided 
evidence for consistent RNA quality and validated the use of Ct values when comparing 
DEFB103 transcript abundance.  
The comparison of DEFB103 transcript abundance among all tissues surveyed in 10- to 14- 
day-old Holstein calves revealed buccal epithelium had a significantly (P < 0.05) higher 
expression level than all other tissues surveyed (Figure 3.2). Other tissues with stratified 
squamous epithelium, including tongue, nictitating membrane, and skin, from a variety of body 
sites, had the next high level of DEFB103 expression and shared a similar level of transcript 
abundance (Figure 3.2a). Trachea, with pseudostratified epithelium, had the next highest level of 
DEFB103 transcript abundance that was similar to lymph nodes draining the skin (Figure 3.2a). 
The rumen, which also contains stratified squamous epithelium, had over 100-fold less 
DEFB103 transcript than buccal epithelium (Figure 3.2a). Furthermore, a wide variety of other 
tissues, including the gastrointestinal tract, other internal organs, and blood had detectable 
DEFB103 transcript levels that were over 1000-fold less than buccal epithelium (Figure 3.2b). 
Thus, buccal epithelium appeared to be unique in its level of DEFB103 gene expression. 
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 Figure 3.2: DEFB103 gene expression in tissues collected from healthy 10- to 14-day-old 
calves. Expression of the DEFB103 gene was analyzed by Real-Time qRT-PCR and is expressed 
as change in threshold cycle (Ct) relative to -actin. Lower Ct values represent increased 
transcript abundance. RNA was isolated from 27 tissues (9 shown in a and 18 in b) collected 
from 10- to 14-day-old calves (n = 9). Each set of tissues was analyzed separately. Data 
presented are the mean + SEM and bars within each panel with different letters are significantly 
different (P <0.05).  
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3.4.2 Effect of age on DEFB103 gene expression 
Tissues with stratified squamous epithelium had the most abundant DEFB103 transcript in 
10- to 14-day-old calves. These tissues were then collected from 10- to 12-month-old calves to 
determine if there was an age-dependent change in DEFB103 expression levels. Similar levels of 
DEFB103 expression were observed in skin, rumen, and tongue of newborn and older calves but 
there was a significant (P < 0.05) decrease in DEFB103 transcript abundance in the buccal 
epithelium of older animals (Figure 3.3). Thus, buccal epithelium also appeared to be unique in 
that age influenced the level of DEFB103 expression.  
  
Figure 3.3: Age-dependent changes in DEFB103 gene expression. DEFB103 gene expression 
was compared to tissues with a high level of expression in newborn calves (10-14 days; n = 9) 
with similar tissues collected from adult (10-12 months; n = 4) animals. DEFB103 gene 
expression was quantified by Real-Time qRT-PCR and expressed as a change in threshold cycle 
(Ct) relative to -actin. Lower Ct values represent increased transcript abundance. Data 
presented are the mean + SEM and bars with different letters are significantly different (P 
<0.05). 
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3.4.3 Effect of gender and viral infection on DEFB103 gene expression  
Gender has been associated with significant differences in the expression of a wide variety 
of innate immune-related genes (Seillet et al., 2012). Therefore, we compared DEFB103 
transcript abundance in tongue, and buccal epithelium collected from 6- to 8-month-old female 
and castrated male calves, following an upper respiratory tract infection by BHV-1. No 
significant (P=0.09) gender difference was observed for either of these tissues (Figure 3.4a), and 
data were then combined to determine if a BHV-1 infection in the upper respiratory tract altered 
DEFB103 gene expression. DEFB103 transcript abundance remained unchanged in tongue 
epithelium when comparing tissues collected from uninfected and infected calves. In contrast, 
DEFB103 expression was significantly (P < 0.05) up-regulated in the buccal epithelium of 
infected 6- to 8-monthold-old calves when compared to healthy 10- to 12-month-old calves 
(Figure 3.4b). Thus, buccal epithelium appears to be a site where both age and viral infection can 
modulate DEFB103 expression. 
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Figure 3.4: The effect of gender and viral infection on DEFB103 gene expression in the upper 
respiratory tract. a DEFB103 gene expression was compared in tissues collected from the oral 
cavity of 6- to 8- month-old infected male (n=5) and female (n=5) calves on day 14 following an 
experimental BHV-1 infection. b DEFB103 gene expression was compared in tissues collected 
from the oral cavity of BHV-1 infected (n = 10) and uninfected (n = 4) calves. DEFB103 gene 
expression was quantified by Real-Time qRT-PCR and expressed as a change in threshold cycle 
(Ct) relative to -actin. Lower Ct values represent increased transcript abundance. Data 
presented are the mean + SEM and bars with different letters are significantly different (P 
<0.05). 
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 3.4.4 DEFB103 protein expression in epithelial tissues 
Transcript abundance may not correspond directly with protein abundance due to rapid 
mRNA degradation, restricted mRNA translation, or differences in protein turnover time 
(Boisvert et al., 2012). Therefore, immunohistochemistry (IHC) was used to confirm that tissues 
with stratified squamous epithelium, where the DEFB103 transcript was most abundant, also 
expressed a high level of DEFB103 protein and to identify cells within epithelial tissues that 
produced DEFB103 protein. 
Specificity of the affinity-purified rabbit antisera raised to the 46–55 epitope in bovine 
DEFB103 was confirmed in several ways. First, amino acid sequence alignment for DEFB103 
and other known bovine beta-defensins determined that only three amino acids in peptide 46–55 
(QIG) and peptide 56–67 (CCR) were common among all bovine β-defensins (Figure 3.1a). This 
level of conservation was considered insufficient to result in cross-reactive antisera (Pierce 
Custom Services). A concentration-matched, irrelevant affinity-purified rabbit antisera was also 
used to control for non-specific binding of rabbit IgG in tissue sections. No visible staining was 
observed with the irrelevant rabbit IgG in buccal epithelium collected from fetal and newborn 
calves (Figure 3.5a; Negative Control i and iv). Finally, bladder that had a very low level of 
DEFB103 transcript (Figure 3.2b) was not visibly stained by the affinity-purified rabbit anti-
bovine DEFB103 (Figure 3.6a). In contrast, tissue sections of buccal epithelium stained with 
affinity-purified rabbit anti-DEFB103 displayed intense staining localized to the basal epithelial 
cell layer but no visible staining of the dermis (DP) and superficial layers of the epidermis 
(Figure 3.5a; Bovine DEFB103 ii and v). While visible DEFB103 staining was restricted 
primarily to the single layer of basal epithelial (BE) cells in 10- to 14-day-old calves, there was 
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visible staining of both basal epithelial cells and several layers of epithelial cells superficial to 
the basal epithelium within the fetal buccal epithelium. (Figure 3.5a ii and v; Table 3.1).  
 
Figure 3.5: Immunohistochemical staining of buccal epithelium (a), bovine nictitating 
membrane (third eyelid) (b) and skin (c) with an irrelevant affinity-purified rabbit antisera (anti-
human CCR5 protein; i and iv), affinity purified rabbit anti-bovine DEFB103 (ii and v) and 
monoclonal antibody specific to CD205 protein expressed on dendritic cells (DCs) ( iii and vi). 
Staining presented is representative of that observed for tissues collected from fetuses (i, ii, and 
iii) and 10- to 14-day-old calves (iv, v, and vi). BE basal epithelial cell layer at the junction 
between the epidermis and dermis; DP dermal papillae are dermal projections into the epithelial 
cell layer of the skin. Scale bars 50 M  
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Figure 3.6: Immunohistochemical staining of a bladder and b rumen with irrelevant affinity-
purified rabbit antisera specific to human CCR5 protein (Negative Control), affinity purified 
rabbit anti-bovine DEFB103, and a monoclonal antibody specific for CD205 protein expressed 
on dendritic cells (DCs). Staining presented is representative of that observed for tissues 
collected from three animals. BE basal epithelial cell layer at the junction between the epidermis 
and dermis; Epi surface outer keratinized surface of the epithelial tissue. Scale bars 50 M 
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IHC staining of nictitating membrane and skin, two other stratified squamous epithelial 
tissues with abundant DEFB103 transcript, revealed similar patterns of DEFB103 protein 
expression with some distinct tissue differences (Table 3.1). Nictitating membrane collected 
from three, 10- to 14-day-old calves consistently displayed visible staining for DEFB103 in basal 
epithelial cells but also throughout the entire epithelial layer, including stratified squamous 
epithelium (Figure 3.5b v; Table 3.1). In contrast, nictitating membrane collected from three 
fetuses displayed weak DEFB103 expression in the basal epithelial cell layer and throughout the 
entire epithelial layer (Figure 3.5b ii; Table 3.1). Selected areas of the panels in Figure 3.5 for 
both buccal epithelium and nictitating membrane collected from fetuses and 10- to 14-day-old 
calves were magnified to better reveal the marked differences in cellular staining patterns for 
DEFB103 protein in these tissues (Figure 3.7). Skin collected from both 10- to 14-day-old calves 
and fetuses displayed similar patterns of DEFB103 staining which were restricted primarily to 
the basal epithelial cell layer, including cells adjacent to the base and sides of hair follicles 
(Figure 3.5c ii and v; Table 3.1).  
Rumen was the only gastrointestinal tissue with a level of DEFB103 transcript similar to 
other tissues containing stratified squamous epithelium (Figure 3.2a). Rumen epithelium consists 
of stratified squamous epithelium, rather than the simple columnar epithelium that is present in 
the small and large intestine. Rumen tissue collected from 10- to 14-day-old calves revealed 
specific but weak DEFB103 is staining throughout the epithelial layer (Figure 3.6b).  
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Figure 3.7: Magnified image of DEFB103 and CD205 staining in a buccal epithelium and b 
nictitating membrane. BE basal epithelial cell layer at the junction between the epidermis and 
dermis; DP dermal papillae; Epi surface outer surface of the epithelial cell surface. Arrows 
indicate DCs. Scale bars 50 M 
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Table 3.1: IHC staining of DEEB103 protein and DCs in tissues with stratified squamous 
epithelium 
Tissue Cell layer Age DEFB103 Stainingb  Dendritic cellsc 
Buccal epitheliuma  
Epidermis Fetus ++; +; ++ +; +; + 
 
 Calf –; +; – –; +; – 
 Basal cells Fetus +++;+++;+++ +;+;+ 
  Calf +++;+++;+++ ++;++;+ 
 Dermis Fetus –;–;– +;–;+ 
  Calf –;–;– +;+;+ 
     
Nictitating membranea Epidermis Fetus +;–;+ –;–;+ 
 Calf +++;+++;+++ ++;++;++ 
 Basal cells Fetus +;–;– +;–;– 
  Calf ++;+++;++ ++;++;++ 
 Dermis Fetus –;–;– –;–;+ 
  Calf –;–;– +;+;+ 
     
Skina  Epidermis Fetus –; +; – –;–;– 
  Calf +;+;+ –;–;– 
 Basal cells Fetus ++;++;+++ +;+;+ 
  Calf +++;+++;+++ +;+;+ 
 Dermis Fetus –;–;– +;+;+ 
  Calf –;–;– +;+;+ 
aTissues were collected from 3 fetuses (7.5-8.5 months gestation) and three newborn 
calves (10-14 days old) 
bStaining intensity for tissue sections from individual animals: – no visible staining; + 
faint visible staining; ++ distinct visible staining; +++ very strong staining 
c Dendritic cell abundance in tissue sections from individual animals: – none visible; + 
rare positive cell; ++ numerous positive cells  
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IHC staining of CD205+ DCs was completed to determine if there was a correlation 
between the pattern of DEFB103 expression in epithelial tissues and the localization or 
abundance of DCs (Figure 3.5a iii and vi). Numerous CD205+ DCs were observed in close 
proximity to basal epithelial cells in buccal epithelium collected from both 10- to 14-day-old 
calves and fetuses (Figure 3.5a iii and vi; Figure 3.7a), where DEFB103 protein expression was 
abundant. In contrast, DC localization was very different in nictitating membranes collec ted from 
10- to 14-day-old calves and fetuses (Figure 3.5b iii and vi; Figure 3.7 b; Table 3.1). Numerous 
DCs were associated with the basal epithelial cell layer and scattered throughout the entire 
epithelial layer of nictitating membranes collected from 10- to 14-day-old calves (Table 3.1). 
This pattern of DC distribution overlapped with the expression of DEFB103 protein throughout 
the epithelial layer of the nictitating membrane. In contrast, few CD205+ DCs were present in 
fetal nictitating membranes where there was weak staining for DEFB103. A close association 
between basal epithelial cells and CD205+ DCs was also observed in skin collected from both 
fetuses and 10- to 14-day-old calves (Figure 3.5c iii and vi). Furthermore, this association was 
present not only in areas of stratified squamous epithelium but also extended to the basal 
epithelium associated with hair follicles in the dermis, where DEFB103 protein was abundant in 
both fetuses and 10- to 14-day-old calves. Thus, the distribution and abundance of DEFB103 
protein were consistent with the hypothesis that DEFB103 may play a role in DC recruitment in 
tissues with stratified squamous epithelium.  
 3.5  Discussion 
Although little is known about the innate immune function of DEFB103, the expression of 
this gene has been analyzed in a wide variety of human and dog tissues. Harder et al. (2001) 
analysed the expression of the HBD3 gene, the ortholog of DEFB103, in a wide variety of tissues 
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and reported 10 to 100-fold higher expression levels in skin and tonsils than all other tissues, 
including the tongue. Garcia et al. (2001) also used Real-Time qRT-PCR to analyzed HBD3 
expression in a wide variety of human tissues but did not analyze skin, tonsil, or tissues from the 
oral cavity. They reported the highest level of HBD3 expression in placenta and testis, but it is 
not possible to directly compare their HBD3 transcript abundance data with either Harder et al. 
(2001) or our current data. One marked contrast between our study and Garcia’s results (2001), 
however, was the reported expression of HBD3 in human neutrophils, whereas we found 
DEFB103 expression was very low in bovine neutrophils (Figure 3.2b). Thus, significant 
interspecies differences may exist in tissue-specific DEFB103 gene expression.  
CBD103 gene expression has also been analyzed in dog tissues (Candille et al., 2007; 
Leonard et al., 2012). Leonard et al. (2012) studied CBD103 gene expression in a limited number 
of tissues collected from dogs of an unspecified age and breed, and reported approximately 104 
transcript copies per 10 ng total RNA in tongue and skin but very low mRNA transcript copy 
number (< 20 copies/10 ng RNA) in lung, bone marrow and epididymis. No transcript was 
detected throughout the gastrointestinal tract, kidney or pancreas. Similar to what was reported 
for dog tissues, we also observed that the DEFB103 gene was highly expressed in a variety of 
oral cavity tissues such as buccal epithelium and tongue (Figure 3.2a) and other tissues with 
stratified squamous epithelium, such as nictitating membrane (third eyelid) and skin. Thus, it 
appears that in humans, dogs, and cattle the oral cavity and skin are important sites for DEFB103 
gene expression. Sorensen et al. (2003) reported that a combination of transforming growth 
factor-α (TGF-α) and insulin- like growth factor-I (IGF-I), both important in wound healing, can 
increase HBD3 expression levels by 5- fold. DEFB103 may also play an important role in 
maintaining the epithelial barrier, especially at sites such as the oral cavity where abrasions can 
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occur while eating. This may be more pronounced in species, such as ruminants, that feed on 
forages and require repeated mastication to break down fibrous material.  
Epithelial tissues from 10- to 14-day-old calves expressed similar levels of the DEFB103 
transcript as older animals, except buccal epithelium (Figure 3.3). Staining intensity for 
DEFB103 protein in buccal epithelium was very high in both 10- to 14-day-old and fetal calves 
but the pattern of DEFB103 staining changed markedly after birth (Figure 3.5a panels ii and v; 
Table 3.1). Thus, there may be a significant shift in the regulation of DEFB103 expression in 
buccal epithelial cells between birth and two weeks of age. The first week of life postpartum has 
been characterised as a time of rapid changes in gene expression throughout the bovine 
gastrointestinal tract and many of these changes were correlated with the exposure to commensal 
microflora (Liang et al., 2014). This may be consistent with the hypothesis that DEFB103 plays a 
significant role, either through wound repair or DC recruitment, in maintaining the epithelial 
barrier. Similarly, infection, by an epitheliotropic viral also resulted in significantly (P < 0.05) 
increased DEFB103 transcript abundance in the buccal epithelium (Figure 3.4b). Tissues were 
sampled at a single time point following viral infection, and further investigations will be 
necessary to determine when DEFB103 expression is greatest. A collection of serial samples 
may determine if DEFB103 expression increases early during infection when the virus is first 
causing epithelial cell destruction or after viral clearance when epithelial cell repair is occurring. 
These studies will provide greater insight into how external stimuli modulate DEFB103 gene 
expression levels. 
There are numerous reports that bacterial infections alter β -defensin gene expression in a 
variety of species and tissues. For example, bovine β-defensin 5 (DEFB5) gene expression 
increased in infected mammary glands (Goldammer et al., 2004) but no significant association 
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was found between DEFB103 gene expression and nasal Staphylococcus aureus carriage status 
in humans (Fode et al., 2011). Ishimoto et al. (2006) reported that patients with pneumonia had 
higher serum HBD3 concentrations only during infection. Santoro et al. (2013) also reported that 
the level of CBD103 transcript increases significantly in dogs with atopic skin versus healthy 
dogs. This finding, however, contradicts a previous study by Leonard et al. (2012). Increased 
DEFB103 gene expression may, therefore, be a specific response to individual pathogens, sites 
of infection, or the age of an animal. Our current study did not implicate gender as a potential 
factor influencing DEFB103 expression (Figure 3.4a), but the strength of this observation may 
be limited by the use of sexually immature animals and the comparison of females with castrated 
males.  
IHC analysis of DEFB103 protein expression in a variety of tissues (Figure 3.5 ii and v) 
was consistent with the DEFB103 gene expression data (Figure 3.2) and revealed that DEFB103 
protein was expressed primarily in basal epithelial cells of stratified squamous epithelium but 
with some differences in distribution among epithelial tissues (Figure 3.5a and c; Table 3.1). 
Furthermore, production of the DEFB103 protein began during fetal development, prior to 
exposure to environmental antigens or infectious agents. The level of DEFB103 expression 
appeared to be much lower, however, in some fetal tissues, such as the nictitating membrane 
(Figure 3.5b ii; Table 3.1). 
 Leonard et al. (2012) also reported IHC staining of CBD103 in the canine skin but did not 
report localization of the protein to basal epithelial cells. Our current observation that DEFB103 
protein was expressed primarily in basal epithelial cells may have significant implications for the 
recruitment and retention of DCs, such as Langerhans cells, in the skin. β-defensins have been 
implicated in DC recruitment (Diamond and Ryan, 2011) and specific DC subpopulations, such 
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as Langerhans cells, play a critical role in immune surveillance in the skin (Malissen et al., 
2014). Bovine Langerhans cells establish a close relationship with epithelial cells in the skin of 
cattle (Bryan et al., 1988) but it is not known when or how DCs are first recruited to the skin. 
Harvey et al. (2013) performed in vitro studies to confirm that human DEFB103 
functioned as both a positive and negative regulator of cytokine and chemokine responses in both 
mouse and human myeloid DCs. The close association between CD205+ DCs and basal epithelial 
cells in fetal and newborn calf stratified squamous epithelium (Figure 3.5 iii and vi; Figure 3.7; 
Table 3.1) suggests that DEFB103 may play a similar role in regulating DC recruitment and 
retention in the skin. Further studies will be required, however, to characterize the particular 
function that bovine DEFB103 may play in localisation of skin DCs and whether this activity is 
specific for individual DC subpopulations, such as Langerhans cells. Skin functions as potent 
immune induction site (Levin et al., 2014), and it will be important to determine which defensins 
play a crucial role in recruiting DCs to maintain immune surveillance and induce immune 
responses following infection. 
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4.0 IDENTIFICATION OF A NEW NON-CODING EXON AND HAPLOTYPE 
VARIABILITY IN THE CATTLE DEFB103 GENE3 
 4.1 Abstract  
The DEFB103 gene is a member of the β-defensin gene family. In this study, we applied 
multiple sets of primers to characterize the DEFB103 transcript. RT-PCR was used to determine 
the cDNA boundaries, and it indicated that the cDNA start point is at least 514 bp before the start 
codon and not further than 678 bp. Also, the length of the 3′UTR was determined to be at least 
53 bp after the stop codon. Seven SNPs were located in the 5′UTR and comprised four different 
haplotypes in genomic DNA. This haplotype data could prove that at least two complete copies 
of DEFB103 with an ATG start codon are present in cDNA in most cattle. In addition, haplotype 
data indicated that there are also multiple incomplete copies in most cattle. A non-coding exon 
1a and a 261 bp intron 1a were identified in cattle and subsequently predicted in sheep and goats. 
DEFB103 sequence assemblies and partial cloning sequences revealed two types of deletion (4-
bp and 8-bp) in the 5′UTR. These observations could prove that these copies are not assembly 
artifacts. 
 4.2 Introduction 
Defensins are members of a cationic protein family (3-4 kDa) with six conserved cysteine 
residues that create three cysteine disulfide bonds (Ganz and Lehrer, 1994). These conserved 
                                                 
3 A version of this chapter has been published: Mirabzadeh-Ardakani, A., Griebel, P. and 
Schmutz, S.M. Identification of a new non-coding exon and haplotype variability in the 
cattle DEFB103 gene. Gene 551 (2014a), pp. 183-8. 
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cysteines provide three different patterns for the disulfide bonds, that divide the defensin family 
into three subfamilies called α, β (Lehrer and Ganz, 1999), and θ-defensins (Tang et al., 1999). β-
defensins are in a single gene cluster in cattle, and they were mapped to chromosome 27 
(Gallagher et al., 1995). β-defensin 103 (DEFB103) is a multi- functional gene influencing innate 
immunity (Bevins, 2006), coat color in dog (Candille et al., 2007), and body weight control in 
mice (Candille et al., 2007). All members of the β-defensin gene family in humans have two 
exons and one intron, with the exception of DEFB105 (GenBank NM_152250.2) which has three 
coding exons and two introns (Pazgier et al., 2006). 
Data from mRNA-seq showed that alternative splicing occurs in more than 90% of 
human genes (Pan et al., 2008; Wang et al., 2008). Genes with alternative promoter regions tend 
to generate alternative splicing (Xin et al., 2008). Microphthalmia-associated transcription 
factor (MITF) with nine exons (Tassabehji et al., 1994) and Insulin-like growth factor 2 (IGF2) 
with ten exons (Goodall and Schmutz, 2007) are such genes. In most genes with alternative 
splicing, some of the exons (Goodall and Schmutz, 2007) or part of the exons (Udono et al., 
2000) are non-coding.  
β-defensins are variable in their copy number (Hollox et al., 2003). DEFB103 copy 
number variation has been reported in humans (2-12 copies per diploid genome) by Hollox et al. 
(2003) and in dogs (2-4 copies per diploid genome) by Leonard et al. (2012). Cattle DEFB103 
occurs in multiple copies in at least some individuals, based on sequence results from a cloning 
experiment (GenBank KM347983, KM347984, KM347985, and KM347986). Five SNPs were 
reported in the 5′UTR of the DEFB103 by Dreger and Schmutz (2009) (c.-319A>G, c.-264C>T, 
c.-69A>G, c.-42A>G, and c.-34G>A), and two additional SNPs (c.-383A>G, c.-241G>A) were 
identified in the 5′UTR of the DEFB103 (Mirabzadeh-Ardakani et al., 2014b). The current 
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research was conducted to investigate gene structure and haplotype variation of DEFB103 in 
different tissues collected from dairy and beef cattle.  
 4.3 Materials and Methods 
 4.3.1 Sample collection 
Animals used for this study were humanely killed according to Canadian Council on 
Animal Care guidelines and protocols approved by the University of Saskatchewan Animal Care 
Committee. Tissue samples were collected from seven neonatal Holstein calves and five 6- to 8-
month-old Angus-cross beef calves. Tongue, buccal epithelium, conjunctiva, rumen, skin, 
trachea, and liver from newborn calves and tongue, buccal epithelium, trachea, and hard palate 
from Angus-cross calves were collected immediately after euthanasia and stored in RNA later® 
(Applied Biosystem-Ambion) in -80 ºC. Whole blood samples (5 ml) were collected from the 
jugular vein of each animal in a BD Vacutainers® with EDTA as an anticoagulant.  
 4.3.2 DNA and total RNA extraction 
DNA was extracted from the buffy coat using an SQ blood DNA kit (OMEGA Bio-Tek, 
Inc.). Total RNA was extracted from collected tissues stabilized by RNAlater® using the TRIzol 
method (Invitrogen). After the first step of extraction, the extracted RNA was treated with 
DNase-I (RNase-free; Invitrogen) to exclude any DNA contamination. The RNA quantity and 
quality were determined using a NanoDrop 2000 (NanoDrop, Technologies, DE, 
USA) spectrophotometer after the first extraction, and using an Agilent 2100 Bioanalyzer 
(G2938B, Agilent Technologies, Mississauga, Ontario) after the second RNA extraction. RNA 
with an integrity number higher than 7 was considered acceptable as intact RNA for cDNA 
preparation.  
53 
 
 4.3.3 Reverse transcription and cDNA synthesis  
Total RNA (250 ng) was reverse-transcribed using qScriptTM cDNA SuperMix (Quanta 
BiosciencesTM), following the manufacturer’s protocol. The cDNA was diluted to 1:10 as a 
template for the reverse transcription-polymerase chain reaction (RT-PCR). 
 4.3.4 Semi nested-PCR and RT-PCR amplification and genotyping  
A stepwise walking procedure was used to design a 5′ forward primer approximately 
every 100bp. The furthest one that could amplify a fragment was selected for the experiment. 
Primers (Table 4.1) were designed using Primer3web (http://bioinfo.ut.ee/primer3/) except 
KNEST1-F and KNEST1-R primers (Dreger and Schmutz 2009). Since beta-defensin genes have 
multiple copies in cattle (Elsik et al., 2009), a semi nested-PCR was used for genomic DNA 
(gDNA) in an attempt to exclude various products or possible pseudogenes. In the primary PCR 
reaction, KNEST1-F forward and KNEST1-R reverse primers (Table 4.1) were used to amplify a 
1925 bp fragment of genomic DEFB103 that includes the 5′UTR, both previously reported 
exons, the intron, and the 3′UTR. The primary PCR product was used as a template for the semi-
nested PCR. In the semi-nested amplification reaction, the same forward (KNEST1-F) and the 
KDEFEX1-R reverse primers (Table 4.1) were used to amplify the 5′UTR, and exon 1 (786 bp).  
In the RT-PCR, three primer pairs (Table 4.1) were used to characterize the cDNA of the 
DEFB103 gene. All the PCR products were separated using 1% agarose gels and then amplified 
products were extracted using a Gel-Extraction Kit (OMEGA Bio-Tek, Inc.). The extracted 
purified PCR products were sequenced (NRC-PBI, Saskatoon), and then analyzed using 
Sequencher software (version 4.8) to determine genotype and then haplotype for the seven SNPs 
in the 5′UTR of the DEFB103 gene.  
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Table 4.1: Primers used in this study. 
Primer Name Starting bpa Primer Sequence 5'-…-3' Template 
Product Size 
(bp) 
Temp (°C) 
KNEST1-F -514 GCGTATCCATGCAGGTTCAG 
Genomic  1925 63 
KNEST1-R *545 AGGCCTGAGGTCAGTCAGAACA 
      
KNEST1-F -514 GCGTATCCATGCAGGTTCAG 
Genomic  786 60 
KDEFEX1-R 58+188 GATTAGTCTCTTAAGAGTGAATCAGAA 
      
KNEST1-F -514 GCGTATCCATGCAGGTTCAG 
cDNA 573 or 312 63 
DEFEX1-R 38 CCTGGAACAGGCAGCAAGAACA 
      
DEFB103-5′UTR-3 -687 AGACACCTTCCTGACTCACG 
cDNA 746 60 
DEFEX1-R 38 CCTGGAACAGGCAGCAAGAACA 
      
KNEST1-F -514 GCGTATCCATGCAGGTTCAG 
cDNA 511 60 
DEFB103Ex2-R2 *53 CTGGAGGAGGCATTTTCACG 
a Based on coding DNA reference sequence.  
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 4.3.5 Haplotype determination 
The five reported SNPs by Dreger and Schmutz (2009) formed two particular haplotypes. 
Two new SNPs in the 5′UTR increased the number of haplotypes from 2 to 4 (Mirabzadeh-
Ardakani et al., 2014b). Two hundred and five Holstein cattle were genotyped for the seven 
SNPs in the 5′UTR of DEFB103 (Mirabzadeh-Ardakani et al., 2014b). Haplotypes were initially 
identified in homozygous cattle. No animal presented a particular genotype that could not be 
explained by these four haplotypes (Table 4.2). 
 
Table 4.2: Diploid haplotypes in genomic DNA. 
Diploid 
haplotype 
c.-383 
A>G 
c.-319 
A>G 
c.-264 
C>T 
c.-241 
G>A 
c.-69 
A>G 
c.-42 
A>G 
c.-34 
G>A 
1/1 AA GG TT GG GG GG AA 
1/2 AA GG TT AG GG GG AA 
1/3 AA AG CT AG AG AG AG 
1/4 AG AG CT AG AG AG AG 
2/2 AA GG TT AA GG GG AA 
2/3 AA AG CT AA AG AG AG 
2/4 AG AG CT AA AG AG AG 
3/3 AA AA CC AA AA AA GG 
3/4 AG AA CC AA AA AA GG 
4/4 GG AA CC AA AA AA GG 
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 4.4 Results 
 4.4.1 SNP haplotypes in genomic DNA  
Cattle were first genotyped for the seven known SNPs in the 5′UTR of DEFB103. Four 
haploid haplotypes were determined for these seven SNPs (c.-383A>G, c.-319A>G, c.-264C>T, 
c.-241G>A, c.-69A>G, c.-42A>G, and c.-34G>A) in Holstein cattle (Mirabzadeh-Ardakani et 
al., 2014b) (Table 4.3). Although the four haploid haplotypes that were previously identified 
were present in both Holstein dairy cattle and beef cattle, in the calves studied in this experiment, 
only haploid haplotypes 2, 3, and 4 were present in the genomic DNA of the Holsteins, and only 
haploid haplotypes 2, and 4 were present in the genomic DNA of the beef calves.  
 4.4.2 Characterization of cDNA start and end positions 
Two primer pairs (KNEST1-F and DEFB103Ex2-R2; DEFB103-5′UTR-3 and DEFEX1-
R) (Table 4.1, Figure 4.1) were used to determine the start (in the 5′UTR) and the end (in the 
3′UTR) of the DEFB103 cDNA transcript in a tongue cDNA sample. A RT-PCR product (511 
bp) was obtained using the KNEST1-F and the DEFB103Ex2-R2 primers. However, no fragment 
was obtained using the DEFB103-5′UTR-3 and the DEFEX1-R primers. The DEFEX1-R reverse 
primer had been designed in exon 1, and it must have a complementary site in the cDNA 
transcript. Therefore, the DEFB103-5′UTR-3 forward primer in the 5′UTR did not have a 
complementary site in the cDNA transcript. As a result, the start of the DEFB103 transcript was 
determined to be at least 514 bp before the start codon (-514, Figure 4.1), and not further than 
678 bp. The length of the 3′UTR was determined to be at least 53 bp after the stop codon (*53, 
Figure 4.1).  
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 Figure 4.1: Characterization of the start and end points of the DEFB103 cDNA transcript. Arrows with the same 
pattern indicate primer pairs used for this determination.  
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Table 4.3: Haploid haplotypes  
  c.-383A>G c.-319A>G c.-264C>T c.-241G>A c.-69A>G c.-42A>G c.-34G>A 
Haplotypesa 
(including intron 
1A)  
1 A G T G G G A 
2 A G T A G G A 
3 A A C A A A G 
4 G A C A A A G 
  c.-383A>G in intron 1a in intron 1a in intron 1a c.-69A>G c.-42A>G c.-34G>A 
Haplotypesb  
(intron 1a spliced 
out) 
X A - - - G G A 
Y A - - - A A G 
Z G - - - A A G 
a Haplotypes derived from genomic DNA (from all cattle studied in this project) and partial copy cDNA (1-4) 
b Haplotypes derived from partial and complete copies of cDNA (X-Z) 
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 4.4.3 SNP haplotypes in cDNA  
At the beginning of this study, KNEST1-F and DEFEX1-R primers (Table 4.1) were used 
to amplify a 573 bp fragment of DEFB103 and genotype the seven SNPs in the 5′UTR. 
However, two PCR products (573 bp and 312 bp) were amplified by using cDNA from the oral 
cavity tissues (tongue, buccal, hard palate), conjunctiva, rumen, bladder, trachea and liver as a 
template (Figure 4.2a and b; Appendix B), but only one product was amplified (573 bp) from the 
skin and lung cDNA (Figure 4.2a). Both PCR products were sequenced and were aligned to 
genomic DNA. This allowed us to determine that a 261 bp fragment was spliced out in the 
5′UTR of DEFB103 in the 321 bp PCR product. At the 5′ end of intron 1a, there is a donor site 
(GT), and at the 3′ end of this fragment, there is an acceptor site (AG) for splicing (Figure 4.2b). 
Having these splicing sites before the first coding exon introduces a new intron (intron 1a) and a 
non-coding exon (exon 1a) before the first coding exon in cattle DEFB103 (312 bp product) 
(Figure 4.2b). The same sequence was in the partial cDNA (573 bp), but splicing did not occur in 
this partial copy, which suggests that the partial copies of DEFB103 were not all identical. 
Sequences with intron 1a spliced out and including intron 1a had a different number of 
SNPs included because 3 of the SNPs (c.-319A>G, c.-264C>T, and c.-241G>A) were in the 
fragment that was intron 1a in some copies. Haplotypes in the partial cDNA product including 
intron 1a (573 bp) include all seven SNPs, therefore, their haplotypes were named like the 
genomic DNA haplotypes, by numbers (Table 4.3) whereas the haplotypes for copies that had 
intron 1a were named by letters (Table 4.3). The haploid haplotypes 1 and 2 in the genomic 
DNA are equivalent to haploid haplotype X, 3 is equivalent to Y, and 4 is equivalent to Z in 
partial cDNA product with the intron 1a (312 bp). Some cattle had more than one diploid 
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haplotype based on repeated PCR reactions, suggesting that a different copy was amplified on 
different occasions (Table 4.4). 
 
 
 
 
 
Figure 4.2: Observed forms of cDNA prepared from cattle RNA. a) A 573 bp partial cDNA 
(including intron 1a). b) A 312 bp partial cDNA when KNEST1-F and DEFEX1-R primers were 
used (intron 1a spliced out), and a 511 bp functional cDNA transcript when KNEST1-F and 
DEFB103EX2-R2 primers were used (intron 1a spliced out).  
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Table 4.4: Diploid haplotype in genomic DNA, partial cDNA (PCR by using KNEST1-F and DEFEX1-R primers), and the 
presumptive functional cDNA (PCR by using KNEST1-F, DEFB103EX2-R2 primers). 
Haplotype from Tissue 
Holstein calves  Angus-cross calves 
A B C E H I J K  N O P Q T 
gDNA Blood 2/4 3/4 2/2 2/3 3/4 3/4 2/4 3/4  2/4 2/4 2/2 2/2 2/2 
Partial cDNA 
(including intron 1a) 
Bladder 1/4 1/4 1/4  1/4     - - - - - 
Liver 1/4 1/4 1/4  1/4 1/4    - - - - - 
Lung 1/4 1/4 1/4 1/2 1/4 1/4 1/2   - - - - - 
Rumen 1/4 1/4 1/4 1/2 1/4 1/4  1/2  - - - - - 
Rumen        3/4  - - - - - 
Skin 1/4 1/4 1/4 1/2 1/4 1/4 1/2   - - - - - 
Skin 3/4 3/4 3/4 3/4 3/4  3/4   - - - - - 
Conjunctiva      3/4    - - - - - 
Buccal 1/4 1/4 1/4 1/2 1/4 1/4 1/2   1/4 1/4 1/3 1/4  
Tongue 1/4 1/4 1/4 1/2 1/4 1/4 1/2 3/4  1/4 1/4 1/4 1/4 2/4 
Tongue 2/4 3/4 3/4   3/4 3/4   3/4 3/4 2/4 3/4  
Trachea 1/4 1/4 1/4 1/2 1/4 1/4 1/2   1/4 1/4 1/4 1/4  
Trachea       3/4   3/4   3/4  
Hard palate - - - - - - - -  1/4 1/4 1/4 1/4 2/4 
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Table 4.4: Continued 
Haplotype from Tissue 
Holstein calves  Angus-cross calves 
A B C E H I J K  N O P Q T 
Partial cDNA 
(intron 1a 
spliced out) 
Bladder    X/Z      - - - - - 
Liver    X/Z   X/Z   - - - - - 
Liver    X/X      - - - - - 
Rumen X/Z
a 
X/Z X/X X/X X/Y X/X    - - - - - 
Conjunctiva  Y/Z X/X X/X X/Y X/X    - - - - - 
Buccal X/Z Y/Z X/X  Y/Z Y/Z    X/Z X/Z  X/X X/X 
Tongue X/Z Y/Z X/X X/Z X/Y Y/Z X/X X/Y  X/Z X/Z X/X X/X X/X 
Tongue    X/X   X/Z        
Trachea X/Y  X/X X/Z X/X X/Z      X/X   
Hard palate  - - - - - - - -    X/X   
Complete cDNA 
(intron 1a 
spliced out) 
Rumen   X/X X/X      - - - - - 
Skin X/X  X/X X/Y Y/Z X/Z X/Z   - - - - - 
Conjunctiva  Y/Z X/X X/X X/Z Y/Z    - - - - - 
Buccal X/Z Y/Z X/X X/Y Y/Z Y/Z X/X   X/Z X/Z  X/X X/X 
Tongue X/X Y/Z X/X X/X   X/Z Y/Z  X/Z X/Z X/X X/Z X/X 
Tongue             X/X  
Trachea X/X  X/X X/Y X/X  X/X        
Hard palate  - - - - - - - -  X/Z X/Z X/X  X/X 
a X/X in cDNA is equivalent with 1/1, 1/2, 2/2 in genomic DNA. X/Y is equivalent with 13, and 23. X/Z is equivalent 
with 14, and 24. Y/Y is equivalent with 33. Y/Z is equivalent with 34. Z/Z is equivalent with 44.  
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To study this further, the same forward (KNEST1-F) and DEFB103EX2-R2 reverse 
primers (Table 4.1, Figure 4.2b; Appendix C) were used to amplify a fragment that includes both 
previously known coding exons. Only one PCR product of 511 bp was amplified in all of the 
tissues, and this piece included intron 1a (Figure 4.2b). However, a second haplotype was often 
observed in individual animals when the PCR reaction was repeated. This observation suggests 
that more than one copy included three exons and two introns. Based on this evidence, we 
conclude the 511 bp cDNA represents a functional transcript of DEFB103 (GenBank KJ461433) 
because of the presence of both coding exons in this transcript.  
 4.4.4 SNP haplotypes in genomic DNA versus cDNA  
 Haplotypes from the partial cDNA including intron 1a (573 bp) were not always 
consistent with the genomic haplotype based on DNA extracted from the blood of the same 
individual (Table 4.4). As an example, two haplotypes (1/4, and 3/4) were observed in skin and 
tongue in animal C, despite the fact that its haplotype in genomic DNA was 2/2. Haplotype 
results from partial cDNA with intron 1a spliced out (312 bp) for most of the tissues from a 
particular animal were consistent with their equivalent genomic haplotype (Table 4.4), with the 
exception of animal E. In the presumptive functional cDNA transcript that includes both coding 
exons and intron 1a, most of the tissues in all of the animals were consistent with their equivalent 
genomic haplotype. This suggests that more than one functional copy and multiple partial copies 
are present in DEFB103, and the CNV could explain this in defensins (Elsik et al., 2009). 
 4.4.5 DEFB103 genomic 5′UTR in different species  
A 590 bp sequence from the 5′UTR of Bos taurus (cattle) DEFB103 was used to BLAST 
the genomic DNA sequences from 8 different species: Capra hircus (goat), Ovis aries (sheep), 
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Equus caballus (horse), Sus scrofa (pig), Canis lupus familiaris (dog), Tursiops truncatus 
(bottlenose dolphin), Mus musculus (house mouse), and Homo sapiens (human). Among these 
species, sheep and goat were the only species that had a comparable sequence to the 5′UTR of 
cattle DEFB103. Three copies of DEFB103 were observed in sheep and goats based on the 
BLAST output. The genomic homology of these copies varied from 86-94% for sheep and cattle 
and 85-93% for goat and cattle. Further analysis using Sequencher software (version 4.8) 
indicated that sheep and goat have the same splicing sites in their sequence, and, therefore, they 
should also have an intron 1a and non-coding exon 1a. The length of intron 1a is 260 bp in both 
sheep and goat, in comparison to the 261 bp in cattle.  
 4.5 Discussion 
 4.5.1 New DEFB103 gene structure 
It is not uncommon for genes to have non-coding first exons. The tyrosinase-related 
protein 1 (TYRP1) gene is an example of a gene with a non-coding first exon (Box et al., 1998). 
A non-coding exon before the first coding exon of the DEFB103 gene has not been previously 
reported in any species. There are two ATG codons in exon1a. The first ATG would introduce 
two stop codons (TGA, TAG) and the second one would introduce one stop codon (TAG) before 
exon 1. This is consistent with our interpretation that exon1a is a non-coding exon. The poly A 
tail was not detected in this study, and, therefore, the 3′UTR is longer than 53 bp. The length of 
the 3′UTR varied from 60 nucleotides to about 4000 nucleotides in mammals, and on average it 
is longer than the 5′UTR (Hesketh, 2001). A new gene structure is proposed for the DEFB103 
gene in cattle (Figure 4.3), based on the current study. We also predict that sheep and goats 
would have three exons. Common evolution in these ruminants may explain the similarity in the 
DEFB103 5′UTR sequences.  
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Figure 4.3: Proposed cattle DEFB103 gene structure with a non-coding exon (exon 1a). 
 4.5.2 Alternate splicing site 
Alternate splicing is common in more than 90% of human genes (Pan et al., 2008; Wang 
et al., 2008). The 573 bp partial cDNA had the same splicing site that the 312 bp partial cDNA 
had, but intron 1a was not spliced out in the 573 bp partial cDNA.  
The microphthalmia-associated transcription factor (MITF) gene is involved in multiple 
pathways, such as pigmentation and deafness disorders in humans (Smith et al., 2000; 
Steingrimsson et al., 2004) and coat color or pattern in mice (Moore, 1995; Widlund and Fisher, 
2003), cattle (Philipp et al., 2011) and dogs (Schmutz et al., 2009). MITF has nine exons 
(Tassabehji et al., 1994), but multiple promoters and splicing of alternative first exons generate 
multiple isoforms of MITF (Amae et al., 1998; Yasumoto et al., 1998). Among these isoforms, 
MITF-M has two alternate acceptor sites at the 5′end of exon 6 (3′ end of intron 5) in humans 
(Amae et al., 1998; Yasumoto et al., 1998), mice (Steingrimsson et al., 1994), dogs (Schmutz et 
al., 2009) and cattle (Strom, 2003). These are called MITF-M+ and MITF-M− (Goding, 2000).  
Alternative splicing was also reported in cattle Insulin-like growth factor 2. IGF2 has ten 
exons, and among these, the first seven exons are non-coding (Goodall and Schmutz, 2007). 
Seven isoforms were reported for the IGF2 transcript indicating multiple promoters involved in 
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IGF2 transcription. One of the transcripts (exon 1-3, 8-10), had an alternative donor splicing site 
41 bp downstream from exon two, that is exclusive to liver tissue (Goodall and Schmutz, 2007). 
Both amplicons of DEFB103 (573bp and 312bp) like MITF-M (MITF-M+ and MITF-
M−) and IGF2 (IGF2+41bp and IGF2) represent the alternate acceptor (Strom, 2003) and donor 
(Goodall and Schmutz, 2007) sites, and they amplified simultaneously by PCR.  
 4.5.3 DEFB103 copies in two published assemblies versus RT-PCR results 
Two assemblies are available for Bos taurus genomic sequence in GenBank (Btau 4.6.1, 
and UMD 3.1). DEFB103 sequence previously obtained by Dreger and Schmutz (2009) 
(GenBank EU715240.1) was used to BLAST against both Bos taurus genome sequences (NCBI 
– Annotation Release 103). The BLAST results from these two annotations were analyzed, and 
each copy of this gene was localized based on its predicted position (Figure 4.4).  
The Btau 4.6.1 assembly had two complete copies with an ATG start codon, and the rest 
of the complete copies had ATA instead of an ATG (Figure 4.4). In the Btau 4.6.1 assembly, all 
of the eight recognized copies included exons 1 and 2 and intron 1 while the UMD 3.1 assembly 
had six complete copies, only one of which had an ATG start codon, and multiple incomplete 
copies. The sequence of the third incomplete copy in the UMD 3.1 assembly does not match with 
any sequence obtained in this study. Therefore, it is likely a sequencing artifact. Three different 
small deletions were identified in one or more different copies that began with ATA of these 
assemblies. Among these deletions c.-454_-457delACAC in UMD copy 10 and BTAU copies 6 
and 8; and c.-199_-206delTAATTAAG in UMD copy 11 and BTAU copies 5 and 7, were 
present in the partial copies obtained by previous cloning experiments (GenBank KM347983 and 
KM347984). Therefore, they are probably not sequencing artifacts. These deletions do not occur 
simultaneously. In addition, c.-27_-40delACACCGTCCTGTCC occurred in UMD copy 12.  
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Figure 4.4: Schematic presentations of the location of different DEFB103 copies in the two assemblies (Btau_4.6.1, and 
Bos_Taurus_UMD_3.1; Annotation Release 103). Arrows indicate the orientation of the sequences.  
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In the PCR in this study, using KNEST1-F (forward) and DEFEX1-R (reverse) primers, 
the reverse primer was located at the end of exon 1, and two PCR products with an ATG start 
codon (Figure 4.2a-b) were amplified using these primers. These products might be from a 
complete or partial copy of the gene. These data support both the Btau 4.6.1 and the UMD 3.1 
assemblies because both of them have two copies with ATG. However, in the PCR using the 
KNEST1-F (forward) and the DEFB103EX2-R2 (reverse) primers, only one PCR product (511 
bp) was amplified with an ATG (Figure 4.2b). In this case, the only assembly that could be 
supported is the UMD 3.1 because it has only one complete copy with an ATG start codon. 
Some of the haplotypes from the partial and functional cDNA transcripts are inconsistent with 
the genomic haplotype from the same individual. Since the DEFB103 gene occurs in multiple 
copies in cattle (Dreger and Schmutz, 2009; Elsik et al., 2009), amplifying a different copy or a 
pseudogene is probably the reason for the inconsistency. Since the complete cDNA transcript 
from most of the tissues had the equivalent genomic haplotype in most cattle, we conclude that 
the fragment amplified using genomic DNA was from one of the complete copies, which could 
be functional copies. 
Five cattle (i.e. A, E, I, J, and Q) had two functional copies with different haplotypes, and 
animal H had three. Based on these observations, at least, two complete transcripts of DEFB103 
are present in the cattle genome (Table 4.4). Six cattle (i.e. B, C, N, O, P, and T) had only one 
haplotype for different tissues. Cattle with one haplotype may still have two or more complete or 
functional copies, but they are just homozygous for that haplotype. The presence of two copies 
supports the Btau 4.6.1 assembly, because it has two complete copies, with an ATG start codon. 
However, our results are consistent with parts of both assemblies for the DEFB103 region. So in 
reality, the assembly for DEFB103 might be a mixture of both published assemblies. High 
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Fidelity Duplication (HFDs) regions, >5kb with >99% sequence homology, were identified in 
both assemblies (Zimin et al., 2012), with 3111 HFDs in Btau 4.2 in comparison to 69 in UMD 
3.1. So the eight complete copies could be one of the HFDs in the Btau 4.6.1 assembly. 
In conclusion, two or multiple haplotypes in different tissues in one individual prove that 
DEFB103 has, at least, two partial copies and two complete copies with an ATG start codon. All 
of the complete copies have a non-coding exon (exon 1a), but not all of the partial copies.  
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5. DEFB103 GENOTYPE AND HAPLOTYPE ASSOCIATION STUDIES 
 5.1  Introduction 
The β-Defensin gene family encodes small cationic peptides with antimicrobial activity 
(Ganz, 2003a) that play an important role in the innate immune system (Hazlett and Wu, 2011). 
DEFB103 is a member of the β-Defensin genes cluster (Hardwick et al., 2011).  
Genetic variation in immunopeptides could potentially lead to differences in disease 
susceptibility and/or resistance. In dairy cattle, combined defensin band patterns were 
determined by using PCR-RFLP of different β-Defensin genes. An association with low somatic 
cell count was reported (Ryniewicz et al., 2003). Since somatic cell count is an indicator of udder 
health (Mrode et al., 1998), members of the β-Defensin gene family could be genetic markers of 
udder susceptibility to inflammation, commonly known as mastitis. Mastitis is a serious and 
ongoing problem in dairy cattle (Thompson-Crispi et al., 2014a). Although many forms of 
mastitis respond well to antibiotic treatment, mastitis caused by Staphylococcus aureus does not 
(Royster and Wagner, 2015). Two populations of Holstein cattle that had been exposed to S. 
aureus provided an opportunity to study disease resistance and susceptibility in these animals.  
Shipping fever continues to be a serious health hazard in beef cattle (Apley, 2014; Ng et 
al., 2015). It was reported as a reason for 70-80% of illness and 40-50% of death in USA’s 
feedlots (Hilton, 2014). Shipping fever is commonly caused by bacteria such as Mannheimia 
haemolytica, or viruses such as bovine herpesvirus-1 (BHV-1) (Hodgson et al., 2012; Griebel et 
al., 2014). A challenge trial using these two agents was conducted (Griebel et al., 2014) and we 
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had the opportunity to collect samples from 60 crossbred calves to study potential resistance 
and/or susceptibility relative to their DEFB103 haplotypes. 
Ocular Squamous cell carcinoma or “Cancer-eye” commonly occurs on the epithelial 
surfaces of the conjunctiva (Tsujita and Plummer, 2010). Cancer-eye is more prevalent in cattle 
breeds with the unpigmented skin around the eyes (Stewart et al., 2006), such as Hereford. It 
typically has a late onset, with most affected cattle being greater than 7-8 years of age (Tsujita 
and Plummer, 2010). It is a rapidly developing cancer that often results in the necessity of 
humane euthanasia within months. Our tissue survey of DEFB103 gene expression revealed 
epithelial tissues, including the conjunctiva, have the highest level of DEFB103 gene expression 
(Chapter 3), and it was a motivation to study these diseases further.  
Five SNPs (c.-319A>G, c.-264C>T, c.-69A>G, c.-42A>G, and c.-34G>A) had been 
reported in the 5′UTR of DEFB103 (Dreger and Schmutz, 2009) and two other SNPs were 
discovered in the present study. The purpose of the current study was to evaluate the association 
of these DEFB103 SNPs and haplotypes on Staphylococcus aureus mastitis in two herds of 
Holstein cattle, Cancer-eye in Hereford cattle, and shipping fever in Angus-crossed cattle.  
 5.2  Materials and Methods 
 5.2.1 Cattle Populations 
 5.2.1.1 Mastitis Herds 
The Saskatchewan population (n=113) was composed of Holstein cattle from three herds. 
S. aureus prevalence for these herds was 3.9%, 14.5%, and 42.3% (Robbins, 1992). The 
Pennsylvania population, consisting of four herds (n=92; extracted in 1992), was used as the 
validation population. In previous related studies, these herds were chosen for their high 
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incidence of mastitis, and their management practices that exposed all cows to the risk of 
infection. Milk samples (3-5 ml) had been collected from each quarter of each cow, twice, with a 
one-month interval. Cows that were infected with S. aureus on both samplings were classified as 
having mastitis.  
 5.2.1.2 Hereford Cattle (Cancer-eye) 
We had 49 stored DNA samples collected from cattle diagnosed with Cancer-eye at 
slaughter but did not have appropriate age-matched controls. Therefore, our study was focused 
on determining if a particular DEFB103 genotype or haplotype predominated in this group. We 
also used DNA samples from 40 beef cattle (10 animals each from four major beef cattle breeds: 
Angus, Hereford, Simmental, Charolais) without Cancer-eye with different ages. Cancer-eye was 
identified by an inspecting veterinarian at a slaughter facility.  
 5.2.1.3 Viral and Bacterial Challenged Calves (shipping fever) 
Sixty Angus-cross cattle, 6-8 months of age, were challenged with Mannheimia 
haemolytica, and bovine herpesvirus-1 (BHV-1) (Hodgson et al., 2012; Griebel et al., 2014). 
Nasal secretions were analyzed for interferon-gamma (IFN-γ) levels by capture ELISA (Raggo et 
al., 2000; Griebel et al., 2014). The level of serum haptoglobin also was quantified by capture 
ELISA to verify the response to BHV-1 infection (Godson et al., 1995; Griebel et al., 2014). 
Animals that survived the challenge were euthanized on day 14. DNA was extracted from 59 
blood samples by using an SQ blood DNA kit (OMEGA Bio-Tek, Inc.). 
  
73 
 
 5.2.2 Primer Design and PCR 
β-Defensin genes have multiple copies in cattle (Elsik et al., 2009). A semi nested-PCR 
was used in an attempt to exclude various products or possible pseudogenes. In the primary PCR 
reaction, KNEST1-F forward and KNEST1-R reverse primers (Table 5.1) (Dreger and Schmutz, 
2009) were used to amplify a 1923 bp fragment of DEFB103 that includes the 5′UTR, both 
previously reported exons, the intron, and the 3′UTR. The primary PCR product was extracted 
from a 1% agarose gel (OMEGA Bio-Tek, Inc.). Then the extracted purified primary PCR 
product was used as a template for the semi-nested PCR. In the semi-nested amplification 
reaction, the same forward (KNEST1-F) and the KDEFEX1-R reverse primers (Table 5.1) were 
used to amplify the 5′UTR, and exon 1 (786 bp). The Kdefex1-R was designed using 
Primer3web (http://bioinfo.ut.ee/primer3/). 
These fragments of DEFB103 were amplified using PCR in 15l reactions. The PCR 
reaction contains 1.5 l of 10x PCR Buffer (Fermentas, Thermo Fisher Scientific Inc.), 0.3 l of 
10 mM dNTP, 0.9 l of 25 mM MgCl2, 10 pmol/l each of forward and reverse primers 
(Operon), 0.1 l of 5U/l Taq polymerase (Fermentas, Thermo Fisher Scientific Inc.), 9.2 l 
dH2O, and 1 l of ~50 ng/l DNA template. PCR reactions were incubated at 95 ºC for 5 min 
(initial denaturation), and then followed by amplification for 35 cycles of 95 ºC for 45 s, 
different annealing temperature for each set of primers (Table 5.1) for 45 s, extension at 72 ºC 
for 1 min, and final extension at 72 ºC for 5 min using Stratagene Robocycler Gradient40 
machines. All the PCR products were separated using 1% agarose gel and then amplified 
products were extracted using gel extraction kit (OMEGA Bio-Tek, Inc.). The obtained purified 
PCR products were sequenced at the National Research Council of Canada Plant Biotechnology 
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Institute (NRC-PBI, Saskatoon) using an ABI 3730xl DNA Analyzer (Applied Biosystems®), 
and The BigDye® Terminator v3.1 Cycle Sequencing Kit (Applied Biosystems®). 
Table 5.1: Primers used for genomic DNA. 
Primer  
Name 
Starting 
bpa 
Primer Sequence 5'-…-3' 
Product 
Size 
(bp) 
Annealing 
Temperature 
(°C) 
KNEST1-F -514 GCGTATCCATGCAGGTTCAG 
1925 63 
KNEST1-R *545 AGGCCTGAGGTCAGTCAGAACA 
     
KNEST1-F -514 GCGTATCCATGCAGGTTCAG 
786 60 
KDEFEX1-R 58+188 GATTAGTCTCTTAAGAGTGAATCAGAA 
a Based on coding DNA reference sequence. *indicates the starting point is after the stop codon 
 5.2.3 Genotyping and Haplotype Identification 
Five SNPs (c.-34G>A, c.-42A>G, c.-69A>G, c.-264C>T, and c.-319A>G) were 
previously reported at the 5′ UTR of cattle DEFB103 (Dreger and Schmutz, 2009). Semi-nested 
PCR product sequences were aligned using the Sequencher software (version 4.8, Gene Codes 
Corporation, Ann Arbor, MI USA) to genotype cattle for each SNP. Haploid haplotypes were 
determined based on the genotype of the SNPs at the 5′ UTR.  
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 5.2.4 Statistical Analysis 
 5.2.4.1 Mastitis Herds, and Hereford Cattle (Cancer-eye) 
GraphPad Prism, version 6.01 was used to analyze the data (GraphPad Software, Inc., 
San Diego, CA). A two-tailed Fisher Exact test was used to determine if there was a significant 
difference in the presence or absence of S. aureus among the cattle of each diploid haplotype. To 
determine if a particular haplotype might be acting as a dominant allele to impart resistance or 
susceptibility to S. aureus, a Fisher Exact test was performed to compare the number of 
individuals with each haplotype versus those individuals who did not have that haplotype, with 
or without mastitis. Relative risk (RR) and odds ratios (OR) (95% confidence interval) were 
calculated. Relative risk and/or odds ratios are often reported for a particular genotype or 
haplotype that may impart some level of resistance to a disease (Lang and Secic, 2006). The 
Fisher exact test also was used to verify whether a particular DEFB103 haplotype is associated 
with the relative risk of Cancer-eye. P<0.05 was considered statistically significant.  
 5.2.4.2 Viral and Bacterial Challenged Calves (shipping fever) 
GraphPad Prism, version 6.01 was used to analyze the data (GraphPad Software, Inc., 
San Diego, CA). A Chi-Square test was used to verify whether there is a significant difference 
between survives and death rate in different haplotypes. A one-way ANOVA was used to verify 
whether there is a significant difference between the level of serum haptoglobin (μg/ml), and 
interferon-gamma (IFN-γ) (ng/ml) in steers (n=33) and heifers (n=26) with different diploid 
haplotype. An unpaired t-test was used to test whether there is a significant difference between 
the level of serum haptoglobin (μg/ml) and interferon-gamma (IFN-γ) (ng/ml) in the different 
diploid haplotype. 
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5.3  Result 
 5.3.1 Mastitis Herds 
Two novel SNPs (c.-241G>A, and c.-383A>G) were identified in this study (Genbank 
KF545952.1). Four haplotypes were determined based on the five SNPs that had been reported 
by Dreger and Schmutz (2009) and these two new SNPs (Table 5.2). 
There was a trend toward increased risk of mastitis in cows with the 1/4 diploid haplotype 
(P = 0.053), in the Saskatchewan population, when compared to individuals with other 
haplotypes (Table 5.3). In the Pennsylvania population, there was a trend toward decreased risk 
of mastitis in cows with the 4/4 diploid haplotype (P = 0.06), when compared to other haplotypes 
(Table 5.3). Therefore the results of these two studies are not consistent and therefore can not be 
considered as a significant finding in either case.   
Table 5.2: Haploid haplotypes in genomic DNA and cDNA. 
 
 
c.-383 
A>G 
c.-319 
A>G 
c.-264 
C>T 
c.-241 
G>A 
c.-69 
A>G 
c.-42 
A>G 
c.-34 
G>A 
Genomic and 
Partial cDNA 
haplotypes 
(including intron 
1a) 
1 A G T G G G A 
2 A G T A G G A 
3 A A C A A A G 
4 G A C A A A G 
 
In the Saskatchewan population, the number of individuals that had, at least, one copy of 
haplotype 2 (P = 0.09) showed a trend toward decreased risk of mastitis. On the other hand, the 
number of individuals that had, at least, one copy of haplotype 4 (P = 0.09), showed a trend 
toward increased risk of mastitis (Table 5.4). The relative risk and the odds ratios results (Table 
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5.4) indicate that individuals with S. aureus infection in the Saskatchewan population, with 
haploid haplotypes 2 and 3, and in the Pennsylvania population with haploid haplotypes 1 and 4 
were less susceptible to mastitis. There was no consistent diploid or haploid haplotype that 
imparted resistance or susceptibility to S. aureus between the two populations. 
 
Table 5.3: The DEFB103 diploid haplotypes in cattle with S. aureus mastitis. Two-tailed P-
values are reported based on a Fisher Exact test.  
Haplotype 
Saskatchewan Population   Pennsylvania Population  
Mastitis  No Mastitis  P  Mastitis No Mastitis P 
1/1 1 1 0.49  0 0 - 
1/2 3 8 0.99  1 1 0.37 
1/3 1 4 0.99  0 2 0.99 
1/4 4 2 0.05  0 3 0.99 
2/2 2 12 0.34  4 7 0.23 
2/3 0 7 0.19  3 8 0.69 
2/4 7 19 0.99  6 24 0.99 
3/3 1 3 0.99  0 3 0.99 
3/4 7 14 0.60  5 12 0.33 
4/4 6 11 0.56  0 13 0.06 
Total 32 81   19 73  
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Table 5.4: The DEFB103 haploid haplotypes of cattle with and without S. aureus mastitis.  
Haplotype P-valuea 
Mastitis  No Mastitis Relative Risk Odds Ratio 
Yes No  Yes No (95% CI) (95% CI) 
Saskatchewan Population         
1 0.31 9 23  15 66 1.52 (0.74-3.11) 1.72 (0.66-4.47) 
2 0.09 12 20  46 35 0.66 (0.41-1.07) 0.46 (0.20-1.06) 
3 0.66 9 23  28 53 0.81 (0.43-1.53) 0.74 (0.30-1.82) 
4 0.09 24 8  46 35 1.32 (1.00-1.74) 2.28 (0.92-5.69) 
Pennsylvania Population         
1 0.99 1 18  6 67 0.64 (0.08-5.00) 0.62 (0.07-5.49) 
2 0.19 14 5  40 33 1.34 (0.96-1.89) 2.31 (0.75-7.08) 
3 0.59 8 11  25 48 1.30 (0.66-2.28) 1.40 (0.50-3.92) 
4 0.28 11 8  52 21 0.63 (0.54-1.22) 0.56 (0.20-1.57) 
                                           
   aTwo-tailed P-values are reported based on the Fisher Exact test. 
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 5.3.2 Cancer-eye Cattle 
The six single nucleotide polymorphisms (SNPs) (c.-34G>A, c.-42A>G, c.-69A>G, c.-
264C>T, c.-319A>G, and -383A>G) were identified in the 5’UTR of DEFB103 in beef cattle. 
The c.-241G>A SNP was not polymorphic in this group of cattle. These six SNPs occurred in 
two haplotypes (2 and 4, Table 5.2) in the 49 Cancer-eye DNA samples from Hereford cattle. 
Haplotype and allelic frequencies were calculated for cattle affected with Cancer-eye and healthy 
beef cattle. All possible combinations of DEFB103 haplotypes were identified among the 
samples (2/2, 2/4, and 4/4, Table 5.5). The Fisher exact test was used, and no significant 
difference (P = 0.43) in haplotype frequencies was observed among the 49 Hereford cattle with 
cancer-eye when compared to 40 healthy beef cattle (10 animals each from four major beef cattle 
breeds: Angus, Hereford, Simmental, Charolais). The minor allele frequency for SNPs in 
Cancer-eye samples was 26%, and in healthy beef cattle was 33.75%. Although the 40 “control” 
samples were from cattle of various ages, we conclude that sampling age-matched healthy 
Hereford cattle samples as a control group would not alter the DEFB103 allele frequency in 
animals free of Cancer-eye. 
Table 5.5: Haplotype frequencies in Hereford cattle with Cancer-eye and healthy beef cattle (10 
animals from four major beef cattle breeds: Angus, Hereford, Simmental, Charolais). 
Diploid 
Haplotype 
a Hereford cattle with Cancer-eye a Healthy beef cattle 
 n Frequency  n Frequency 
2/2  27 0.55  19 0.47 
2/4  19 0.39  15 0.38 
4/4  3 0.06  6 0.15 
Total  49   40  
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 5.3.3 Viral and Bacterial Challenged Calves (shipping fever) 
The seven SNPs (c.-34G>A, c.-42A>G, c.-69A>G, c.-241G>A, c.-264C>T, c.-319A>G, 
and -383A>G) were identified in the 5’UTR of DEFB103 in Angus-crossed cattle. These seven 
SNPs occurred in three haplotypes (1, 2 and 4, Table 5.2) in the 59 Angus-crossed cattle. All 
possible combinations of DEFB103 haplotypes were identified among the samples (Table 5.6) 
except 1/4 diploid haplotype. Very few cattle were identified with the 1/1, 1/2, and 4/4 diploid 
haplotypes (Table 5.6). Because of their low frequency, only cattle with 2/2 and 2/4 diploid 
haplotypes were used in the analyzes.  
Table 5.6: Diploid Haplotype frequency in the Angus' calves. 
Diploid Haplotype Number Frequency 
1/1 1 0.02 
1/2 3 0.05 
2/2 23 0.39 
2/4 30 0.51 
4/4 2 0.03 
  
 5.3.3.1 Survival Post Infection 
A Chi-Square test indicated that there was no significant difference in survival time 
between steers (n=33) and heifers (n=26) with a 2/2 or 2/4 diploid haplotype (P=0.93). Steers 
and heifers were pooled for further analysis. A Log-rank (Mantel-Cox) indicated that there was 
no significant difference in the survival curve between cattle with diploid haplotypes 2/2 and 2/4 
(P=0.50; Figure 5.1). 
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Figure 5.1: Survival Post-Infection. Cattle on the day 14th survived. 
 5.3.3.2 Levels of serum haptoglobin (μg/ml) and interferon-gamma (IFN-γ) (ng/ml) 
The level of serum haptoglobin (μg/ml) indicates a level of response to bacterial 
inflammation at 24 hours after bacterial challenge (Godson et al., 1995). A one-way ANOVA 
showed that there was no significant difference between the level of serum haptoglobin (μg/ml) 
in steers (n=33) and heifers (n=26) with a 2/2 or 2/4 diploid haplotype (P=0.38). Steers and 
heifers were pooled for further analysis. An unpaired t-test result indicated that there was no 
significant difference between the level of serum haptoglobin (μg/ml) in cattle with 2/2 and 2/4 
diploid haplotypes (P=0.65; Table 5.7). 
The peak of virus replication is five days after BHV-1 infection (Raggo et al., 2000) 
which coincides with the peak of interferon production (Raggo et al., 2000; Hodgson et al., 
2012). A one-way ANOVA indicated that there was no significant difference between the level 
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of interferon-gamma (IFN-γ) (ng/ml) in steers (n=33) and heifers (n=26) with a 2/2 or 2/4 diploid 
haplotype (P=0.30). Steers and heifers were pooled for further analysis. An unpaired t-test result 
indicated that there was no significant difference between the level of interferon-gamma (IFN-γ) 
(ng/ml) (Table 5.7) in cattle with 2/2 and 2/4 diploid haplotypes (P=0.50; Table 5.7). 
Table 5.7: Serum haptoglobin (microgram/ml) and interferon-gamma (IFN-γ) (ng/ml) 
concentration in 2/2 and 2/4 diploid haplotypes.  
Parameter 
Diploid Haplotype 
P-value 2/2  
(n=23) 
2/4  
(n=30) 
Serum haptoglobin (μg/ml)  2943 ± 1591.6*  3167.2 ± 1878.8 P=0.65 
Interferon-gamma (IFN-γ)(ng/ml) 6363 ± 6661 8085 ± 10623 P=0.50 
* mean ± SD 
 5.4  Discussion 
All the animals in these three disease association studies were genotyped for SNPs in the 
5′UTR of the DEFB103 gene by designing a semi-nested PCR (Table 5.1). Four haploid 
haplotypes (Table 5.2) were determined based on the seven SNPs (c.-383A>G, c.-319A>G, c.-
264C>T, c.-241G>A, c.-69A>G, c.-42A>G, and c.-34G>A) in beef and Holstein cattle. The 
frequency and the number of haplotypes were different in beef and Holstein cattle populations. 
All the possible haploid haplotypes (n= 4) were identified in Holstein cattle based on the seven 
SNPs. While only two haploid haplotypes (2 and 4) were identified in Hereford cattle with 
Cancer-eye and other healthy beef cattle that were analyzed in the Cancer-eye study (Table 5.5). 
In the viral and bacterial-challenged calves (Angus breed) three haploid haplotypes (1, 2 and 4) 
were determined, but the frequency of the haploid haplotype 1 in Angus' calves (0.04; Table 5.6) 
was lower than in Holstein cattle (0.11; Table 5.3).  
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The Angus samples, collected for the shipping fever study in 2012, were the only beef 
cattle having haploid haplotype 1. The other samples from a variety of beef cattle breeds 
including Angus, Hereford, Simmental, and Charolais that were tested for DEFB103 SNP 
identification at the early stage of this project were collected in the early 1990s. They did not 
have haploid haplotype 1. Whereas Holstein samples from the early 1990s in the current mastitis 
study had haploid haplotype 1. Since selection strategies developed in the beef cattle industry in 
the past years, the haploid haplotype 1 may have arisen independently by indirect selection in 
beef cattle over this time. 
Although haploid and diploid haplotypes were studied in two Holstein populations 
regarding mastitis, no significant association was found. The trend toward increased and 
decreased the risk of mastitis was identified in the two cattle population in this study. The small 
sample size probably affected the outcome of this study (Table 5.3). The statistical analysis 
would be more reliable if we had a bigger sample size for each haploid or diploid haplotype. 
Antimicrobial peptides affect some mastitis pathogens. Nocardia Gram-negative bacteria 
may cause bovine mastitis (Ribeiro et al., 2008). An In vitro study showed, that hBD-3, the 
human equivalent of cattle DEFB103 had the strongest activity against N. nova and N.farcinica 
in comparison to other human antimicrobial peptides (Rieg et al., 2010). 
Seven to eight years of age is the peak age of onset for Cancer-eye in cattle (Tsujita and 
Plummer, 2010). Animals of the available control group in the Cancer-eye study were younger 
than seven years of age. They were therefore not considered to be an appropriate control for this 
study. However, all the diploid haplotype combinations (including 2/2, 2/4 and 4/4) were found 
between Hereford cattle with Cancer-eye and healthy beef cattle. The haplotype frequencies of 
these two groups of animals had no significant difference (P= 0.43).  
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The most common site for Cancer-eye development is the nictitating membrane. The 
current DEFB103 gene expression study showed a high level of expression in the nictitating 
membrane in 10-14 day-old calves (Figure 3.2 a; Figure 3.5b). Determining the DEFB103 gene 
expression in nictitating membrane tissue of older animals may help us to explain the possible 
association of this cancer and DEFB10 expression.  
Calves in the shipping fever study were inoculated with Mannheimia haemolytica, and 
bovine herpesvirus-1 (BHV-1). The BHV-1 and the herpes simplex virus (HSV) are members of 
Alphaherpesvirinae subfamily, and they have similar activity and both cause infection in the 
respiratory tract (Graham and Snell, 1983; Jones, 2003). hBD-3 has been shown to interfere with 
herpes simplex virus infection in humans (Hazrati et al., 2006). Herpes simplex virus has 
glycoprotein B and heparan sulfate receptors on its surface. The hBD-3 binds to these two 
receptors and inhibits infection by preventing HSV binding and entry (Hazrati et al., 2006).  
A DNA vaccine that encodes the mature peptide of bovine β-defensin 3 was designed to 
protect cattle from bovine herpes virus 1 (Mackenzie-Dyck et al., 2014). The DNA vaccine did 
not prevent bovine herpes virus 1 infection, but it did improve the cell-mediated immune 
responses. This result may support the lack of association between the DEFB103 haplotypes and 
shipping fever in our study because of vaccine failure, but it does not support the immune 
response results.  
In this study, it has been shown that DEFB103 complete and partial transcripts have an 
intron (intron 1a) before the first coding exon (Table 4.3; Figure 4.2). Intron 1a excludes 3 SNPs 
(c.-319A>G, c.-264C>T, c.-241G>A) from the transcript haplotypes (Table 4.3). Therefore, 
these three SNPs would not be transcribed in cDNA. The new haploid haplotypes derived from 
transcripts were called X (equivalent to haploid haplotype 1 and 2), Y (equivalent to haploid 
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haplotype 3), and Z (equivalent to haploid haplotype 4). Transcripts are the active form of the 
gene. Therefore, new analyses were done for the mastitis and the shipping fever study using the 
new diploid haplotypes (X/X, X/Z, and Z/Z), but they did not change the earlier results based on 
haplotypes that included all 7 SNPs. 
Some cattle or calves had two different diploid haplotypes in their incomplete or 
complete transcripts (Table 4.4). For example, tongue tissue in animal Q has X/X and X/Z 
diploid haplotypes. Based on this observation, some of the animals in the three studies in this 
chapter may have more than two diploid haplotypes of DEFB103 in target tissues, and this may 
affect the results and their inconsistency.  
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6.0 GENERAL DISCUSSION 
 6.1 DEFB103 Gene Expression 
Most diseases are multifactorial in etiology, and they may be controlled by multiple 
genes, as well as environmental triggers. Therefore, understanding the genetic basis of disease 
susceptibility may not be as simple as identifying a single gene with a dominant or a recessive 
effect.  
Gene expression results are more accurate when no primer-dimers form or genomic DNA 
(gDNA) contamination is absent from qRT-PCR reactions. In this situation, cDNA is the only 
template for the primers (Laurell et al., 2012). Competition of gDNA and cDNA for primers and 
dNTPs in qRT-PCR may affect the efficiency of the reaction (Laurell et al., 2012). Genomic 
DNA (gDNA) contamination also may shift Ct values especially in genes with lower gene 
expression (Yee et al., 2014).  
Complementary DNA samples were used for both qRT-PCR (gene expression) and RT-
PCR (cDNA haplotype analysis) studies. To minimize the possibility of gDNA contamination, 
all RNA samples were treated with DNase-I (RNase-free; Invitrogen). Primers were designed 
that targeted two coding exons with an intervening intron. Furthermore, a melting curve analysis 
(Appendix D) was performed to determine whether there was a non-specific product or primer 
dimer formation during the qRT-PCR reactions. All melting curves for each qRT-PCR reaction 
showed single peaks for DEFB103 and B-actin products and confirmed the absence of gDNA 
from cDNA.  
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A gene expression study was conducted for CBD1, CBD103 (DEFB103 ortholog in dogs) 
and CBD108 by Leonard et al. (2012). The CBD103 gene had a more restricted tissue-specific 
expression pattern in comparison to CBD1 and CBD108. CBD103 gene expression was higher in 
skin and tongue in dog which is consistent with our findings. The highest level of hBD-3 
expression was also detected in human skin and tonsils (Harder et al., 2001). In the current study, 
the buccal epithelium was the only tissue that displayed an up-regulation of DEFB103 following 
BHV-1 infection in cattle. In general, stratified squamous epithelial tissues had a high level of 
DEFB103 expression in comparison to the other tissues.  
In vitro treatment of human primary keratinocytes and primary tracheal epithelial cells 
with heat- inactivated bacteria (P. aeruginosa ; 108 cells/ ml) or tumor necrosis factor α (TNF-α; 
10 ng/ml) up-regulated the level of hBD-3 expression (Harder et al., 2001). In the current study, 
the buccal epithelium was the only tissue sampled that significantly up-regulated DEFB103 gene 
expression following BHV-1 infection. This observation supports the conclusion that DEFB103 
gene expression can also be modulated by infectious agents. In this situation, other infection 
disease studies and their relation to DEFB103 gene expression in a target tissue might be useful. 
Further study of the effect of mastitis on DEFB103 gene expression in the mammary gland might 
be important to clarify results of my other studies in Chapter 5. If DEFB103 gene expression 
does not change in the mammary gland during mastitis, then this would be consistent with the 
results reported for DEFB103 haplotype study (Chapter 5). DEFB103 gene expression data may 
also indicate whether mastitis was an appropriate disease to look for correlation with DEFB103 
haplotypes. 
Immunohistochemistry studies confirmed keratinocytes were the main cell type 
expressing DEFB103 in the skin of both humans (Harder et al., 2001) and dogs (Leonard et al., 
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2012). These observations are in agreement with our findings in cattle. , These previous studies 
did not report localized production of DEFB103 protein in basal epithelial cells, as we observed 
in cattle. Some dogs have a 3-bp deletion (KB allele) in the second exon of CBD103 that removes 
a glycine from the amino acid sequence. Dogs with this KB allele have significantly (P = 0.0021) 
increased CBD103 protein levels in their keratinocytes when compared to dogs homozygous for 
the wild-type alleles (ky/ky) (Candille et al., 2007). 
We also observed DEFB103 protein was abundant in the conjunctiva of the bovine eye. 
A high level of protein production in this tissue indicates that ocular diseases may be appropriate 
targets to study when investigating potential associations between DEFB103 alleles and disease 
resistance.  
 6.2 DEFB103 Gene Structure and Its Association with Diseases 
The β-defensin gene cluster contributes to multiple aspects of the innate immune 
responses, and it may influence the development of infectious disease during the initial steps of 
infection that occur within epithelial tissues. In humans, the cluster of β-defensin genes on 
chromosome 8 has 2-12 copies per diploid genome (Hollox et al., 2003). The Btau 4.6.1 and 
UMD 3.1 assemblies verified there were multiple copies of the DEFB103 gene in cattle (Chapter 
4.5.3).  
The number of copies of DEFB103 transcripts (mRNA) was determined based on 
sequence analysis of RT-PCR products extracted from an agarose gel. In this study, at least, two 
complete transcripts of the bovine DEFB103 with different haplotypes were identified for some 
tissues when using RT-PCR (Chapter 4, Table 4.4). At least two complete copies of DEFB103 
transcripts were identified but because of the RT-PCR method used, I cannot conclude whether 
these two complete transcripts were generated from two or more gene copies present in the 
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genome. If the DEFB103 copies have the same haplotype, then it is not possible to distinguish 
between the two copies using RT-PCR. This is a limitation of RT-PCR. Therefore, the number of 
complete transcripts might be more than two copies in some cattle. A copy number variation 
(CNV) study is needed to determine a minimum and a maximum number of DEFB103 copies in 
cattle.  
Using manual annotation, Amid et al. (2009) reported 53 active and 22 pseudogenes (5 
partial) in the major defensin gene cluster region of mouse chromosome 8. Defensin’s 
pseudogenes in mice are not transcribed, so they are not functional (Amid et al., 2009). Another 
example is the neutrophil cytosolic factor 1 (NCF1) gene on chromosome 7 in human. The NCF1 
has segmental duplication (Antonell et al., 2005) and two of the highly similar copies in NCF1 
do not produce functional protein because of a 2-bp deletion in exon 2 (Gorlach et al., 1997). 
All the sequences analyzed from this RT-PCR experiment had ATG as the start codon 
and were identical except for the seven SNPs positions. DEFB103 SNPs are present before the 
start codon. Therefore, we suggest that these two complete transcripts were functional copies of 
the DEFB103 gene. A more detailed DEFB103 protein expression and function study are 
necessary to confirm conclusively that both mRNAs are translated into functional proteins.  
The initial assumption for the DEFB103 gene expression analyses was that all DEFB103 
transcripts were derived from a single copy of the DEFB103 gene. But RT-PCR revealed that 
this assumption was not valid. Because at least two complete copies of DEFB103 have been 
identified in some cattle (Chapter 4, Table 4). I could not include a full characterization of 
transcript copies in the gene expression analysis because there was insufficient sample for each 
age category and we did not determine the actual number of transcript copies present in each 
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sample. If adequate samples were available for each haplotype and different CNVs, the gene 
expression study would have been more informative. 
Genotyping for a gene like DEFB103 with CNV and pseudogenes is complicated. In each 
PCR reaction, one copy of a functional gene or a pseudogene could be amplified predominantly 
and, therefore, SNP genotypes or haplotypes may not be consistent when performing replicate 
assays. The chance of amplifying a pseudogene is higher if a one-step PCR, rather than a nested 
PCR, is used for genotyping since both complete and partial copies of the gene could be 
amplified in this reaction. In this study, all animals were genotyped for seven SNPs in the 5′UTR 
of DEFB103 using nested-PCR (explained in Section 4.3.4; Table 4.1) to exclude partial 
pseudogenes and minimize non-specific amplification. Only complete gene copies were 
amplified by the first PCR. The nested PCR then amplified a smaller gene fragment (about 700 
bp) that was more appropriate for sequencing.  
Complementary DNA samples were used for the RT-PCR with the assumption that no 
gDNA contamination was present. However, at the beginning of this study two PCR products 
(573 bp including intron 1a and 312 bp with intron 1a spliced out) were amplified using 
KNEST1-F and DEFEX1-R primers (Table 4.1; Figure 4.1). Multiple products in RT-PCR could 
be the result of gDNA contamination. Therefore, KNEST1-F and DEFB103EX2-R2 primers 
were used to amplify the complete transcript that includes two coding exons and non-coding 
exon 1a (Figure 4.1b). The complete transcript (511 bp; Figure 4.1b) in all samples had non-
coding exon 1a and intron 1a and no gDNA was amplified (Appendix C).  
Four haploid haplotypes and 10 possible diploid haplotypes were identified in beef and 
Holstein cattle, respectively. Since the number of diploid haplotypes was 10, we did not have 
sufficient samples size for each diploid haplotype to analyze them separately in the mastitis 
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study. This limited the statistical power of our analysis. No significant association was found 
between the DEFB103 haplotypes and mastitis, cancer-eye and shipping fever in this study. 
Including a consideration of CNV and increasing the number of animals sampled may yield 
different results in a future study. 
Wagter and Mallard (2007) patented a test which can identify animals with higher cell-
mediated (CMIR) and antibody-mediated immune responses (AMIR). Thompson et al. (2012) 
reported a lower frequency of infectious and metabolic diseases in Holstein cows with high 
AMIR and High CMIR. Cows with higher AMIR also had a lower incidence of mastitis (Wagter 
et al., 2000; Thompson-Crispi et al., 2012). A genome-wide association study of immune 
response trait revealed a significant association between many genes known to be involved in 
immune response, such as bovine Major Histocompatibility Complex, cytokines, and 
complement system with both high AMIR and CMIR and TAP and DEFB103 were associated 
with high CMIR (Thompson-Crispi et al., 2014c). These findings support the conclusion that 
animal selection based on an individual’s immune responses or genetic profile could improve 
animal health, decrease the cost of treating disease, and increase the profitability of the dairy and 
beef cattle industry. 
 6.3 Future Research 
In this study, RT-PCR was used to determine the start and end points of DEFB103 
cDNA. Three forward primers were designed from 678 bp to 1624 bp beyond the start codon, but 
no fragment was amplified. Therefore, I concluded that the cDNA start point was at least 514 bp 
(KNEST1-F primer position that amplified a fragment) before the start codon and not further 
than 678 bp. The non-coding exon 1a (Figure 4.2b) identified in the 5′ UTR of the DEFB103 
gene was identified in a later experiment. Identification of the non-coding exon 1a in the 5′ UTR 
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indicated the possible presence of one or more non-coding exons beyond the 514 bp upstream of 
the start codon. Therefore, a more detailed study may be needed to determine accurately the start 
point of the 5′ UTR of the DEFB103 gene. The length of the identified non-coding exon 1a based 
on these experiments is, at least, 383bp and not larger than 556 bp. 
The presence of non-coding exon 1a was predicted in sheep and goat based on BLAST 
analysis. An experiment could be conducted to verify the presence of the non-coding exon 1a in 
sheep and goat. If the non-coding exon 1a is also present in sheep and goat, this would indicate 
that the DEFB103 gene structure is conserved in ruminants and differentiate it from other 
species. 
The β-defensin gene family members in the BTA27 cluster have multiple copy numbers 
or CNV, and it has been reported in Chapter 4 that some cattle had more than one haplotype 
based on the repeated PCR reactions in DEFB103 (Table 4.4). Copy number variation for 
DEFB103 among individual animals may have affected the disease association analyses in this 
study. There may be a possible significant association between infectious disease susceptibility 
and DEFB103 gene variation in copy number, but this possible association will need to be 
explored in future studies 
The analysis of DEFB103 gene haplotypes and SNPs did not reveal any significant 
associations with the three diseases studied (Chapter 5). The DEFB103 gene is a member of a β-
defensin gene family, and this gene family is one of the primary gene clusters in the innate 
immunity system. Other β-defensin gene family members could be investigated for potential 
associations with the infectious diseases that I studied. One of the candidate genes for mastitis 
disease might be the β-defensin 5. Goldammer et al. (2004) reported β-defensin 5 gene up-
regulation during mastitis in cattle. LAP protein has also been identified in infected and healthy 
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mammary gland of cattle (Isobe et al., 2009) and its expression in cattle had a positive 
relationship with somatic cell count in milk (Swanson et al., 2004). 
 6.4 Conclusion  
 DEFB103 gene expression and protein was significantly higher in the oral cavity and 
stratified squamous epithelium of skin in comparison to the other tissues collected 
from 14-day-old calves (Figure 3.2a).  
 Buccal epithelium was the only tissue in which DEFB103 gene expression was up-
regulated following infection or down-regulated with increasing age. DEFB103 gene 
expression was significantly increased (p<0.05) in the buccal epithelium of infected 6- 
to 8-month old animals in comparison to healthy 8- to 10-month old animals (Figure 
3.4b). DEFB103 gene expression was significantly decreased (p<0.05) in the buccal 
epithelium of 10- to 12-month old animals in comparison to 10- to 14-day old calves 
(Figure 3.3).  
 A new non-coding exon 1a was reported in the 5′ UTR of the DEFB103 gene. This 
genomic structure has not been reported in any other β-defensin genes studied in other 
species. Two new SNPs were also identified in the 5′ UTR of the DEFB103 gene. The 
combination of two new SNPs and the five previously reported SNPs (Dreger and 
Schmutz, 2009) identified two new haplotypes for DEFB103 gene.  
 In this study, no significant association was found between the DEFB103 haplotypes 
and mastitis, cancer-eye or fetal secondary bacterial respiratory disease following a 
primary BHV-1 infection.  
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8.0  APPENDICES 
Appendix A: Standard curve for primer validation 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
y = -3.2429x + 32.367 
R² = 0.9693 
0 
5 
10 
15 
20 
25 
30 
35 
0 2 4 6 8 
C
t 
V
al
u
e
 
Log amplified copy number 
  
116 
 
Appendix B: Photographs of 1% agarose gels showing a 573 bp partial cDNA (including intron 
1a) and a 312 bp partial cDNA (intron 1a spliced out) when KNEST1-F and DEFEX1-R primers 
were used from 6 cattle (A, B, C, E, J, K). 
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Appendix C: Photographs of 1% agarose gels showing a 511 bp complete cDNA transcript 
when (a) KNEST1-F  and DEFEX1-R and (b) KNEST1-F and DEFB103EX2-R2 primers were 
used  (illustrating potential alternative splicing in seven different cattle).  
a                                                                         b 
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Appendix D: Melting Curve for DEFB103 and B-actin products 
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Appendix E: Abstract for the Annual Life & Health Sciences Research Day March 14th, 2014, 
University of Saskatchewan, Saskatoon 
 
No association between β-Defensin 103B (DEFB103B) mutations or haplotype and Cancer-
Eye in Hereford cattle  
A. Mirabzadeh-Ardakani1, P. Griebel2, and S. M. Schmutz1  
 
Ocular squamous cell carcinoma or “Cancer-eye” commonly occurs in the epithelial surfaces of 
conjunctiva. Cancer-Eye is more common in cattle breeds with unpigmented skin around the 
eyes, such as Hereford. It typically has late onset, with most affected cattle being greater than 7-9 
years of age. It is a rapidly developing cancer that often results in the necessity of humane 
euthanasia within months. One of the important components of innate host defenses is 
antimicrobial peptide production, with cattle β-Defensin 103B (DEFB103B) being one of these 
peptides. Cattle DEFB103B in cattle is homologous to human DEFB3. In this study, Cancer-eye 
was identified by an inspecting veterinarian at a slaughter facility. A tissue survey of DEFB103B 
gene expression revealed epithelial tissues, including the conjunctiva, have the highest level of 
DEFB103B gene expression. Six single nucleotide polymorphisms (SNP) were identified in the 
5’UTR of DEFB103B in beef cattle, and four of these are present in cDNA. These SNPs 
occurred in two haplotypes in the 49 Cancer-eye DNA samples from Hereford cattle. We 
hypothesized that a specific DEFB103B haplotype may be associated with the relative risk of 
Cancer-eye. Haplotype and allelic frequencies were analyzed for cattle affected with Cancer-eye 
and healthy controls. All possible combinations of DEFB103B haplotypes were identified among 
the samples. There was no significant difference in allelic or haplotype frequencies among the 49 
Hereford cattle with cancer-eye when compared to 40 healthy beef cattle (10 animals each from 
four major beef cattle breeds: Angus, Hereford, Simmental, Charolais). The minor allele 
frequency for SNPs in Cancer-eye samples was 26%, and in healthy beef cattle was 33.75%. 
Although the 40 “control” samples are from cattle of various ages, we conclude that sampling 
age-matched healthy Hereford cattle samples as a control group, would not alter the DEFB103B 
allele frequency in animals free of Cancer-eye. 
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Appendix F: Poster presented in the Annual Life & Health Sciences Research Day March 14th, 
2014, University of Saskatchewan, Saskatoon 
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Appendix G: Extended abstract presented in the 10th World Congress of Genetics Applied to 
Livestock Production (WCGALP), August 17–22, 2014, Vancouver, BC. 
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Appendix H: Poster presented in the 10th World Congress of Genetics Applied to Livestock Production (WCGALP), August 17–22, 
2014, Vancouver, BC. 
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Appendix I: Manuscript published in Gene. Mirabzadeh-Ardakani, A., Griebel, P. and Schmutz, 
S.M. Identification of a new non-coding exon and haplotype variability in the cattle DEFB103 
gene. Gene 551 (2014a), pp. 183-8. 
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Appendix J: Manuscript published in Cell and Tissue Research journal. Mirabzadeh-Ardakani, 
A., Solie, J., Gonzalez-Cano, P., Schmutz, S.M. and Griebel, P.J. Tissue- and age-dependent 
expression of the bovine DEFB103 gene and protein. Cell Tissue Res (2015). 
 
